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1. Bacterial strains, plasmids, materials, and instrumentation. 
The bacterial strains utilized in this study were obtained from various sources. E. coli BL21 
(DE3) (M) and S. epidermidis ATCC12228 (A) were purchased from the American Type Culture 
Collection (ATCC) (Manassas, VA, USA). All other E. coli BL21 (DE3) strains (N-Q) were 
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constructed in the Garneau-Tsodikova laboratory. B. subtilis 168 (F) utilized for preparation of 
the B. subtilis containing the AAC(6')/APH(2") (G) was obtained from the Bacillus Genetic 
Stock Center (Columbus, OH, USA). S. aureus NorA (B), methicillin-resistant S. aureus 
(MRSA) (C), vancomycin-resistant Enterococcus (VRE) (J), and E. coli TolC (R) were a gift 
from Prof. David H. Sherman (University of Michigan). S. pyogenes serotype M12 (strain 
MGAS9429) (D) was a gift from Prof. Itzhak Ofek (Faculty of Medicine, Tel Aviv University). 
S. mutans UA159 (E) was a gift from Prof. Doron Steinberg (Faculty of Dental Medicine, The 
Hebrew University of Jerusalem). The Shigella clinical isolate 6831 (T) was a gift from Prof. 
Dani Cohen (School of Public Health, Tel Aviv University). B. anthracis 34F2 Sterne strain (I) 
was a gift from Prof. Philip C. Hanna (University of Michigan). B. cereus ATCC1178 (H), E. 
faecalis ATCC29212 (K), L. monocytogenes ATCC19115 (L), E. coli MC1061 (S), and S. 
enterica ATCC14028 (U) were a gift from Prof. Paul J. Hergenrother (University of Illinois at 
Urbana-Champaign). 
 
B. subtilis containing AAC(6')/APH(2") was prepared as previously reported.1 The AAC(3)-IV2 
and AAC(6')/APH(2"),2 AAC(6')-Ib',3 AAC(6')-IId, Eis,4 AAC(2')-Ic,4 and ANT(4')5 enzymes 
were purified as previously described. 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), ATP, acetyl-
CoA, and inorganic pyrophosphatase were bought from Sigma-Aldrich and used without any 
further purification. TOB was bought from Tzamal D-Chem Laboratories Ltd. All thiols were 
purchased from Alfa Aesar. Compound 2 was prepared as previously described by Tor and co-
workers.6 MTT was purchased from TCI America (Portland, OR, USA). Spectrophotometric and 
colorimetric assays were performed on a multimode SpectraMax M5 plate reader using 96-well 
plates (Fisher Scientific). Chemical reactions were monitored by TLC (Merck, Silica gel 60 F254). 
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Visualization was achieved using a cerium-molybdate stain ((NH4)2Ce(NO3)6 (5 g), 
(NH4)6Mo7O24•4H2O (120 g), H2SO4 (80 mL), H2O (720 mL)). Compounds were purified by 
SiO2 flash chromatography (Merck, Kieselgel 60). 1H NMR spectra (including 1D-TOCSY) and 
13C NMR spectra were recorded on Bruker AvanceTM 400 and 500 spectrometers. High-
resolution electron spray ionization (HR-ESI) mass spectra were measured on a Waters Synapt 
instrument. 
 
2. Chemical methods. 
2.1. Synthesis of Boc-protected 6"-thioether TOB derivatives 3a-r. 
Boc-protected 6"-thioether TOB derivative 3a. To a solution of 
compound 2 (402 mg, 0.32 mmol) and Cs2CO3 (160 mg, 0.49 
mmol) in dry DMF (3 mL), 1-hexanethiol (0.230 mL, 1.63 mmol) 
was added. The reaction mixture was stirred at 55 °C overnight. Completion of the reaction was 
observed by TLC (EtOAc:petroleum ether/3:2, Rf 0.44). The reaction mixture was diluted with 
EtOAc (10 mL) and the organic layer was washed twice with brine (2x5 mL). The aqueous layer 
was extracted again with EtOAc (10 mL) and the combined organic layers were dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Further purification by flash 
column chromatography (SiO2, EtOAc:petroleum ether) gave 3a (250 mg, 72%) as a white solid: 
1H NMR (400 MHz, CD3OD) δ 5.09 (br s, 1H, H-1'), 5.04 (br d, J = 2.4 Hz, 1H, H-1"), 4.07 
(ddd, J1 = 9.2 Hz, J2 = 6.8 Hz, J3 = 2.2 Hz, 1H, H-5"), 3.74-3.28 (m, 13H, H-1, H-3, H-4, H-5, H-
6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4"), 2.99 (br dd, J1 = 14.4 Hz, J2 = 2.1 Hz, 1H, H-
6"), 2.62 (m, 1H, H-6"), 2.59 (t, J = 7.4 Hz, 2H, SCH2(CH2)4CH3), 2.15 (m, 1H, H-2eq), 2.01 (m, 
1H, H-3'eq), 1.60-1.27 (m, 55H, H-2ax, H-3'ax, 5xCO2C(CH3)3, SCH2(CH2)4CH3), 0.91 (t, J = 
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6.6 Hz, 3H, SCH2(CH2)4CH3);	  13C NMR (100 MHz, CD3OD) δ 159.5, 159.3, 157.9, 157.7 (2C), 
100.0 (anomeric C), 99.6 (anomeric C), 84.3, 82.6, 80.7, 80.5, 80.4, 80.2, 77.2, 73.9, 73.5, 72.1, 
66.4, 57.1, 51.5, 51.2, 51.0, 41.9, 35.8, 34.7, 34.3, 34.1, 33.0, 32.6, 31.8, 30.8, 30.7, 30.4, 29.6, 
28.8, 23.7, 14.5; HRESI-MS m/z calc’d for C49H89N5O18SNa 1090.5821, found 1090.5822 
[M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3b. Compound 3b 
was prepared as 3a using compound 2 (502 mg, 0.41 mmol), 
Cs2CO3 (200 mg, 0.64 mmol), dry DMF (5 mL), and 1-octanethiol 
(0.353 mL, 2.03 mmol) at rt overnight. Completion of the reaction was observed by TLC 
(EtOAc:petroleum ether/3:2, Rf 0.53). Purification by flash column chromatography (SiO2, 
EtOAc:petroleum ether) gave 3b (390 mg, 87%) as a white solid: 1H NMR (400 MHz, CD3OD) 
δ 5.09 (br s, 1H, H-1'), 5.04 (br s, 1H, H-1"), 4.07 (ddd, J1 = 9.2 Hz, J2 = 6.8 Hz, J3 = 2.1 Hz, 1H, 
H-5"), 3.73-3.28 (m, 13H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-
4"), 2.99 (br dd, J1 = 14.4 Hz, J2 = 2.0 Hz, 1H, H-6"), 2.62 (m, 1H, H-6"), 2.59 (t, J = 7.3 Hz, 2H, 
SCH2(CH2)6CH3), 2.15 (m, 1H, H-2eq), 2.01 (m, 1H, H-3'eq), 1.68-1.28 (m, 59H, H-2ax, H-3'ax, 
5xCO2C(CH3)3, SCH2(CH2)6CH3), 0.91 (t, J = 6.9 Hz, 3H, SCH2(CH2)6CH3); 13C NMR (100 
MHz, CD3OD) δ 159.5, 159.3, 157.9, 157.7 (2C), 100.0 (anomeric C), 99.6 (anomeric C), 84.4, 
82.6, 80.7, 80.4, 80.2, 77.2, 73.9, 73.5, 72.1, 66.4, 57.1, 51.5, 51.2, 51.0, 42.0, 35.7, 34.7, 34.3, 
34.1, 33.0, 30.8, 30.7, 30.4, 30.0, 28.9, 23.7, 14.5; HRESI-MS m/z calc’d for C51H93N5O18SNa 
1118.6134, found 1118.6130 [M+Na]+. 
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Boc-protected 6"-thioether TOB derivative 3c. Compound 3c 
was prepared as 3a using compound 2 (306 mg, 0.25 mmol), 
Cs2CO3 (145 mg, 0.45 mmol), dry DMF (2 mL), and 1-
decanethiol (0.360 mL, 1.74 mmol) at rt overnight. Completion of the reaction was observed by 
TLC (MeOH:CH2Cl2/0.6:9.4, Rf 0.42). Purification by flash column chromatography (SiO2, 
MeOH:CH2Cl2) gave 3c (262 mg, 94%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 5.09 (br 
s, 1H, H-1'), 5.03 (br d, J = 2.7 Hz, 1H, H-1"), 4.07 (ddd, J1 = 9.2 Hz, J2 = 6.7 Hz, J3 = 2.2 Hz, 
1H, H-5"), 3.72-3.29 (m, 13H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", 
H-4"), 2.99 (br dd, J1 = 14.2 Hz, J2 = 2.1 Hz, 1H, H-6"), 2.62 (m, 1H, H-6"), 2.59 (t, J = 7.4 Hz, 
2H, SCH2(CH2)8CH3), 2.16 (m, 1H, H-2eq), 2.01 (m, 1H, H-3'eq), 1.64 (app. q, J1 = J2 = J3 = 
12.0 Hz, 1H, H-3'ax), 1.61-1.29 (m, 62H, H-2ax, 5xCO2C(CH3)3, SCH2(CH2)8CH3), 0.91 (t, J = 
6.6 Hz, 3H, SCH2(CH2)8CH3); 13C NMR (100 MHz, CD3OD) δ 159.5, 159.3, 157.9, 157.7 (2C), 
100.1 (anomeric C), 99.6 (anomeric C), 84.4, 82.6, 80.7, 80.44, 80.37, 80.2, 77.2, 73.9, 73.6, 
72.2, 66.5, 57.1, 51.5, 51.2, 51.0, 42.0, 35.7, 34.7, 34.3, 34.2, 33.1, 30.9, 30.7, 30.4, 30.5, 30.4, 
30.0, 28.87, 28.84, 28.80, 23.7, 14.5; HRESI-MS m/z calc’d for C53H97N5O18SNa 1146.6447, 
found 1146.6449 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3d. Compound 3d 
was prepared as 3a using compound 2 (303 mg, 0.25 mmol), 
Cs2CO3 (144 mg, 0.44 mmol), dry DMF (2 mL), and 1-
dodecanethiol (0.414 mL, 1.72 mmol) at rt overnight. Completion of the reaction was observed 
by TLC (MeOH:CH2Cl2/0.6:9.4, Rf 0.42). Purification by flash column chromatography (SiO2, 
MeOH:CH2Cl2) gave 3d (260 mg, 92%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 5.09 
O
NHBoc
HO
BocHN
O
NHBoc
NHBoc
O
HO
O
OH
BocHN
HO
S
9
O
NHBoc
HO
BocHN
O
NHBoc
NHBoc
O
HO
O
OH
BocHN
HO
S
11
	   6 
(br s, 1H, H-1'), 5.04 (br d, J = 2.8 Hz, 1H, H-1"), 4.07 (ddd, J1 = 9.2 Hz, J2 = 6.7 Hz, J3 = 2.2 
Hz, 1H, H-5"), 3.71-3.33 (m, 13H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-
3", H-4"), 2.97 (dd, J1 = 14.2 Hz, J2 = 2.2 Hz, 1H, H-6"), 2.61 (m, 1H, H-6"), 2.59 (t, J = 7.3 Hz, 
2H, SCH2(CH2)10CH3), 2.16 (m, 1H, H-2eq), 2.00 (m, 1H, H-3'eq), 1.66-1.27 (m, 67H, H-2ax, H-
3'ax, 5xCO2C(CH3)3, SCH2(CH2)10CH3), 0.90 (t, J = 6.6 Hz, 3H, SCH2(CH2)10CH3); 13C NMR 
(100 MHz, CD3OD) δ 159.5, 159.2, 157.9, 157.7 (2C), 100.0 (anomeric C), 99.6 (anomeric C), 
84.3, 82.5, 80.6, 80.5, 80.4, 80.3, 80.2, 77.1, 73.9, 73.5, 72.1, 66.4, 57.1, 51.5, 51.2, 51.0, 41.9, 
35.7, 34.7, 34.3, 34.1, 33.0, 30.9, 30.7, 30.5, 30.4, 29.9, 28.8, 28.7, 23.7, 14.4; HRESI-MS m/z 
calc’d for C55H101N5O18SNa 1174.6760, found 1174.6757 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3e. Compound 3e 
was prepared as 3a using compound 2 (150 mg, 0.12 mmol), 
Cs2CO3 (72 mg, 0.22 mmol), dry DMF (1 mL), and 1-
tetradecanethiol (0.230 mL, 0.84 mmol) at 55 °C overnight. 
Completion of the reaction was observed by TLC (EtOAc:petroleum ether/3:2, Rf 0.53). 
Purification by flash column chromatography (SiO2, EtOAc:petroleum ether) gave 3e (90 mg, 
63%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 5.09 (br s, 1H, H-1'), 5.04 (br d, J = 2.8 
Hz, 1H, H-1"), 4.07 (ddd, J1 = 9.2 Hz, J2 = 7.1 Hz, J3 = 2.3 Hz, 1H, H-5"), 3.72-3.29 (m, 13H, H-
1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4"), 2.99 (dd, J1 = 14.4 Hz, J2 = 
2.0 Hz, 1H, H-6"), 2.61 (m, 1H, H-6"), 2.59 (t, J = 7.3 Hz, 2H, SCH2(CH2)12CH3), 2.16 (m, 1H, 
H-2eq), 2.00 (m, 1H, H-3'eq), 1.64 (app. q, J1 = J2 = J3 = 12.1 Hz, 1H, H-3'ax), 1.62-1.28 (m, 
70H, H-2ax, 5xCO2C(CH3)3, SCH2(CH2)12CH3), 0.90 (t, J = 7.0 Hz, 3H, SCH2(CH2)12CH3); 13C 
NMR (125 MHz, CD3OD) δ 159.5, 159.3, 158.0, 157.8 (2C), 100.0 (anomeric C), 99.6 
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(anomeric C), 84.3, 82.6, 80.7, 80.5, 80.4, 80.2, 77.2, 73.9, 73.6, 72.2, 66.5, 57.1, 51.5, 51.2, 
51.1, 42.0, 35.7, 34.8, 34.3, 34.2, 33.1, 30.9, 30.80, 30.77, 30.5, 30.4, 30.0, 28.9, 28.84, 28.80, 
23.7, 14.5; HRESI-MS m/z calc’d for C57H105N5O18SNa 1202.7073, found 1202.7075 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3f. Compound 3f 
was prepared as 3a using compound 2 (308 mg, 0.25 mmol), 
Cs2CO3 (105 mg, 0.30 mmol), dry DMF (2 mL), and 
hexadecanethiol (0.229 mL, 0.75 mmol) at 60 °C overnight. Completion of the reaction was 
observed by TLC (EtOAc:petroleum ether/3:2, Rf 0.61). Purification by flash column 
chromatography (SiO2, EtOAc:petroleum ether) gave 3f (190 mg, 63%) as a white solid: 1H 
NMR (400 MHz, CD3OD) δ 5.09 (br s, 1H, H-1'), 5.04 (br s, 1H, H-1"), 4.07 (ddd, J1 = 9.2 Hz, 
J2 = 6.7 Hz, J3 = 2.3 Hz, 1H, H-5"), 3.73-3.30 (m, 13H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-
5', H-6' (2H), H-2", H-3", H-4"), 2.99 (dd, J1 = 14.1 Hz, J2 = 1.7 Hz, 1H, H-6"), 2.61 (m, 1H, H-
6"), 2.59 (t, J = 7.3 Hz, 2H, SCH2(CH2)14CH3), 2.17 (m, 1H, H-2eq), 2.03 (m, 1H, H-3'eq), 1.64 
(app. q, J1 = J2 = J3 = 12.0 Hz, 1H, H-3'ax), 1.61-1.29 (m, 74H, H-2ax, 5xCO2C(CH3)3, 
SCH2(CH2)14CH3), 0.90 (t, J = 7.0 Hz, 3H, SCH2(CH2)14CH3); 13C NMR (100 MHz, CD3OD) δ 
159.4, 159.2, 157.8, 157.6 (2C), 100.0 (anomeric C), 99.5 (anomeric C), 84.1, 82.5, 80.6, 80.3, 
80.2, 77.1, 73.9, 73.5, 72.1, 66.4, 57.1, 51.4, 51.2, 50.1, 42.0, 35.7, 34.7, 34.3, 34.1, 33.0, 30.8, 
30.4, 30.0, 28.89, 28.86, 28.82, 23.7, 14.5; HRESI-MS m/z calc’d for C59H109N5O18SNa 
1230.7386, found 1230.7390 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3g. Compound 3g 
was prepared as 3a using compound 2 (150 mg, 0.12 mmol), 
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Cs2CO3 (48 mg, 0.15 mmol), dry DMF (1 mL), and 1-octadecanethiol (105 mg, 0.36 mmol) at 55 
°C overnight. Completion of the reaction was observed by TLC (EtOAc:petroleum ether/3:2, Rf 
0.53). Purification by flash column chromatography (SiO2, EtOAc:petroleum ether) gave 3g (96 
mg, 64%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 5.09 (br s, 1H, H-1'), 5.04 (br d, J = 
2.6 Hz, 1H, H-1"), 4.07 (ddd, J1 = 9.4 Hz, J2 = 6.8 Hz, J3 = 2.5 Hz, 1H, H-5"), 3.71-3.29 (m, 
13H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4"), 2.99 (dd, J1 = 14.1 
Hz, J2 = 2.1 Hz, 1H, H-6"), 2.61 (m, 1H, H-6"), 2.59 (t, J = 7.3 Hz, 2H, SCH2(CH2)16CH3), 2.16 
(m, 1H, H-2eq), 2.01 (m, 1H, H-3'eq), 1.64 (app. q, J1 = J2 = J3 = 12.0 Hz, 1H, H-3'ax), 1.61-1.28 
(m, 78H, H-2ax, 5xCO2C(CH3)3, SCH2(CH2)16CH3), 0.90 (t, J = 7.0 Hz, 3H, SCH2(CH2)16CH3); 
13C NMR (100 MHz, CD3OD) δ 159.5, 159.3, 157.9, 157.7 (2C), 100.0 (anomeric C), 99.6 
(anomeric C), 84.4, 82.6, 80.7, 80.43, 80.37, 80.2, 77.2, 73.9, 73.6, 72.2, 66.5, 57.1, 51.5, 51.2, 
51.0, 42.0, 35.7, 34.8, 34.3, 34.1, 33.1, 30.8, 30.4, 30.0, 28.88, 28.85, 28.81, 23.7, 14.5; HRESI-
MS m/z calc’d for C61H113N5O18SNa 1258.7699, found 1258.7695 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3h. Compound 3h 
was prepared as 3a using compound 2 (330 mg, 0.27 mmol), 
Cs2CO3 (105 mg, 0.32 mmol), dry DMF (2 mL), and 1-
docosamethiol (275 mg, 0.80 mmol) at 55 °C overnight. 
Completion of the reaction was observed by TLC (EtOAc:petroleum ether/3:2, Rf 0.62). 
Purification by flash column chromatography (SiO2, EtOAc:petroleum ether) gave 3h (197 mg, 
57%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 5.09 (br s, 1H, H-1'), 5.04 (br d, J = 3.1 
Hz, 1H, H-1"), 4.07 (ddd, J1 = 9.4 Hz, J2 = 7.2 Hz, J3 = 2.5 Hz, 1H, H-5"), 3.71-3.30 (m, 13H, H-
1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4"), 2.99 (dd, J1 = 13.9 Hz, J2 = 
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2.0 Hz, 1H, H-6"), 2.61 (m, 1H, H-6"), 2.59 (t, J = 7.3 Hz, 2H, SCH2(CH2)20CH3), 2.16 (m, 1H, 
H-2eq), 2.02 (m, 1H, H-3'eq), 1.64 (app. q, J1 = J2 = J3 = 12.0 Hz, 1H, H-3'ax), 1.61-1.26 (m, 
86H, H-2ax, 5xCO2C(CH3)3, SCH2(CH2)20CH3), 0.90 (t, J = 7.0 Hz, 3H, SCH2(CH2)20CH3); 13C 
NMR (100 MHz, CD3OD) δ 159.5, 159.3, 157.9, 157.7 (2C), 100.1 (anomeric C), 99.6 
(anomeric C), 84.4, 82.6, 80.7, 80.44, 80.37, 80.2, 77.2, 73.9, 73.6, 72.2, 66.5, 57.1, 51.5, 51.2, 
51.1, 42.0, 35.8, 34.8, 34.3, 34.2, 33.1, 30.8, 30.5, 30.0, 28.89, 28.86, 28.82, 23.7, 14.5; HRESI-
MS m/z calc’d for C61H121N5O18SNa 1314.8325, found 1314.8319 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3i. Compound 3i 
was prepared as 3a using compound 2 (320 mg, 0.26 mmol), 
Cs2CO3 (157 mg, 0.48 mmol), dry DMF (2 mL), and 2-methyl-2-
propanethiol (0.205 mL, 1.81 mmol) at rt overnight. Completion 
of the reaction was observed by TLC (MeOH:CH2Cl2/0.6:9.4, Rf 0.44). Purification by flash 
column chromatography (SiO2, MeOH:CH2Cl2) gave 3i (254 mg, 94%) as a white solid: 1H NMR 
(400 MHz, CD3OD) δ 5.11 (br s, 1H, H-1'), 5.01 (br d, J = 2.7 Hz, 1H, H-1"), 4.04 (m, 1H, H-
5"), 3.70-3.25 (m, 13H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4"), 
3.07 (dd, J1 = 13.4 Hz, J2 = 2.3 Hz, 1H, H-6"), 2.62 (dd, J1 = 13.4 Hz, J2 = 7.7 Hz, 1H, H-6") 
2.15 (m, 1H, H-2eq), 1.99 (m, 1H, H-3'eq), 1.65 (app. q, J1 = J2 = J3 = 12.0 Hz, 1H, H-3'ax), 
1.47-1.43 (m, 46H, H-2ax, 5xCO2C(CH3)3), 1.32 (s, 9H, SC(CH3)3); 13C NMR (100 MHz, 
CD3OD) δ 159.5, 159.3, 158.0, 157.8 (2C), 100.4 (anomeric C), 99.5 (anomeric C), 84.7, 82.5, 
80.7, 80.4, 80.2, 77.2, 74.6, 73.6, 72.7, 72.2, 66.5, 57.1, 51.6, 51.2, 43.1, 42.0, 35.6, 35.5, 34.4, 
31.5, 31.2, 30.8, 28.9, 28.8, 25.1, 23.9; HRESI-MS m/z calc’d for C47H85N5O18SNa 1062.5508, 
found 1062.5505 [M+Na]+. 
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Boc-protected 6"-thioether TOB derivative 3j. Compound 
3j was prepared as 3a using compound 2 (304 mg, 0.25 
mmol), Cs2CO3 (144 mg, 0.44 mmol), dry DMF (2 mL), and 
cyclohexanethiol (0.211 mL, 1.72 mmol) at rt overnight. 
Completion of the reaction was observed by TLC (EtOAc:petroleum ether/3:2, Rf 0.36). 
Purification by flash column chromatography (SiO2, EtOAc:petroleum ether) gave 3j (250 mg, 
95%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 5.08 (br s, 1H, H-1'), 5.02 (br d, J = 2.8 
Hz, 1H, H-1"), 4.04 (br ddd, J1 = 9.2 Hz, J2 = 7.4 Hz, J3 = 1.8 Hz, 1H, H-5"), 3.71-3.27 (m, 13H, 
13H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4"), 3.05 (dd, J1 = 14.2 
Hz, J2 = 2.4 Hz, 1H, H-6"), 2.76 (m, 1H, SC6H11), 2.58 (dd, J1 = 14.0 Hz, J2 = 7.4 Hz, 1H, H-6"), 
2.15 (m, 1H, H-2eq), 2.00 (m, 3H, H-3'eq, SC6H11), 1.76 (m, 2H, SC6H11), 1.69-1.25 (m, 53H, H-
2ax, H-3'ax, 5xCO2C(CH3)3, SC6H11); 13C NMR (100 MHz, CD3OD) δ 159.5, 159.3, 158.0, 
157.8, 100.3 (anomeric C), 99.7 (anomeric C), 84.6, 82.7, 80.7, 80.5, 80.4, 80.2, 77.2, 74.2, 73.6, 
72.5, 72.2, 66.4, 57.1, 51.6, 51.2, 51.0, 45.2, 42.0, 35.7, 35.0, 34.7, 34.4, 32.8, 28.9, 28.8, 27.0, 
26.9; HRESI-MS m/z calc’d for C49H87N5O18SNa 1088.5665, found 1088.5667 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3k. Compound 3k 
was prepared as 3a using compound 2 (502 mg, 0.41 mmol), 
Cs2CO3 (200 mg, 0.61 mmol), dry DMF (5 mL), and thiophenol 
(0.210 mL, 2.03 mmol) at rt overnight. Completion of the 
reaction was observed by TLC (EtOAc:petroleum ether/3:2, Rf 0.36). Purification by flash 
column chromatography (SiO2, EtOAc:petroleum ether) gave 3k (308 mg, 71%) as a white solid: 
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1H NMR (400 MHz, CD3OD) δ 7.40 (d, J = 6.0 Hz, 2H, aromatic), 7.30 (app. t, J1 = J2 = 6.0 Hz, 
2H, aromatic), 7.17 (t, J = 5.8 Hz, 1H, aromatic), 5.07 (br s, 1H, H-1'), 5.02 (br s, 1H, H-1"), 
4.10 (m, 1H, H-5"), 3.67-3.31 (m, 14H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-
2", H-3", H-4", H-6''), 3.00 (br dd, J1 = 10.1 Hz, J2 = 5.8 Hz, 1H, H-6"), 2.14 (m, 1H, H-2eq), 
2.04 (m, 1H, H-3'eq), 1.67 (app. q, J1 = J2 = J3 = 9.6 Hz, 1H, H-3'ax), 1.50-1.39 (m, 46H, H-2ax, 
5xCO2C(CH3)3); 13C NMR (100 MHz, CD3OD) δ 159.5, 159.3, 158.0, 157.8, 157.7,137.9, 130.1, 
129.9, 126.9, 100.3 (anomeric C), 99.6 (anomeric C), 84.6, 82.4, 80.7, 80.5, 80.4, 80.2, 77.4, 
73.6, 73.2, 72.4, 72.0, 66.5, 57.1, 51.5, 51.2, 51.0, 42.0, 36.3, 35.7, 34.4, 33.1, 32.0, 31.8, 30.7, 
30.5, 28.9, 28.8; HRESI-MS m/z calc’d for C49H81N5O18SNa 1082.5195, found 1082.5193 
[M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3l. Compound 
3l was prepared as 3a using compound 2 (309 mg, 0.25 
mmol), Cs2CO3 (146 mg, 0.45 mmol), dry DMF (2 mL), and 
4-methylbenzenethiol (218 mg, 1.75 mmol) at rt overnight. 
Completion of the reaction was observed by TLC (MeOH:CH2Cl2/0.6:9.4, Rf 0.42). Purification 
by flash column chromatography (SiO2, MeOH:CH2Cl2) gave 3l (247 mg, 92%) as a white solid: 
1H NMR (500 MHz, CD3OD) δ 7.30 (d, J = 6.5 Hz, 2H, aromatic), 7.13 (d, J = 6.1 Hz, 2H, 
aromatic), 5.09 (br s, 1H, H-1'), 5.01 (br s, 1H, H-1"), 4.05 (m, 1H, H-5"), 3.64-3.31 (m, 14H, H-
1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4", H-6"), 2.93 (br dd, J1 = 10.5 
Hz, J2 = 5.6 Hz, 1H, H-6"), 2.30 (s, 3H, SC6H4(CH3)), 2.17 (m, 1H, H-2eq), 2.03 (m, 1H, H-
3'eq), 1.68 (app. q, J1 = J2 = J3 = 9.5 Hz, 1H, H-3'ax), 1.48-1.44 (m, 46H, H-2ax, 
5xCO2C(CH3)3); 13C NMR (100 MHz, CD3OD) δ 159.4, 159.3, 158.0, 157.8 (2C), 137.1, 134.0, 
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130.8 (2C), 130.6 (2C), 129.1, 100.4 (anomeric C), 99.6 (anomeric C), 84.7, 82.3, 80.7, 80.5, 
80.4, 80.2, 77.4, 73.6, 73.2, 72.4, 72.05, 66.5, 57.1, 51.5, 51.3, 51.0, 42.0, 37.0, 35.7, 34.4, 33.0, 
30.7, 30.4, 28.9, 28.8, 21.0; HRESI-MS m/z calc’d for C50H83N5O18SNa 1096.5352, found 
1096.5350 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3m. Compound 
3m was prepared as 3a using compound 2 (404 mg, 0.33 mmol), 
Cs2CO3 (160 mg, 0.49 mmol), dry DMF (4 mL), and 2,6-
dimethylbenzenethiol (0.217 mL, 1.64 mmol) at rt overnight. Completion of the reaction was 
observed by TLC (EtOAc:petroleum ether/3:2, Rf 0.44). Purification by flash column 
chromatography (SiO2, EtOAc:petroleum ether) gave 3m (275 mg, 77%) as a white solid: 1H 
NMR (400 MHz, CD3OD) δ 7.07 (m, 3H, SC6H3(CH3)2), 5.13 (br s, 1H, H-1'), 5.06 (br s, 1H, H-
1"), 4.19 (m, 1H, H-5"), 3.73-3.27 (m, 13H, H-1, H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), 
H-2", H-3", H-4"), 3.05-2.91 (m, 2H, H-6"), 2.54 (s, 6H, SC6H3(CH3)2), 2.13 (m, 1H, H-2eq), 
1.98 (m, 1H, H-3'eq), 1.64 (m, 1H, H-3'ax), 1.48-1.25 (m, 46H, H-2ax, 5xCO2C(CH3)3); 13C 
NMR (100 MHz, CD3OD) δ 159.5, 159.3, 157.9, 157.7 (2C), 143.9, 135.8, 129.2, 129.1, 100.0 
(anomeric C), 99.3 (anomeric C), 83.7, 82.3, 80.7, 80.4, 80.2, 77.3, 73.9, 73.5, 72.1, 66.5, 57.1, 
51.7, 51.1, 51.0, 41.9, 39.0, 35.9, 35.5, 34.3, 33.0, 32.0, 31.8, 30.7, 30.4, 28.8, 22.6; HRESI-MS 
m/z calc’d for C51H85N5O18SNa 1110.5508, found 1110.5507 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3n. Compound 
3n was prepared as 3a using compound 2 (411 mg, 0.33 
mmol), Cs2CO3 (163 mg, 0.50 mmol), dry DMF (4 mL), and 
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2,4,6-trimethylbenzenethiol (0.251 mL, 1.66 mmol) at rt overnight. Completion of the reaction 
was observed by TLC (EtOAc:petroleum ether/3:2, Rf 0.44). Purification by flash column 
chromatography (SiO2, EtOAc:petroleum ether) gave 3n (306 mg, 83%) as a white solid: 1H 
NMR (400 MHz, CD3OD) δ 6.90 (s, 2H, aromatic), 5.13 (br s, 1H, H-1'), 5.06 (br s, 1H, H-1"), 
4.18 (m, 1H, H-5"), 3.73-3.30 (m, 13H, H-1, H-3, H-4, H-5, H-6, H-2' H-4', H-5', H-6' (2H), H-
2", H-3", H-4"), 2.98 (dd, J1 = 12.6 Hz, J2 = 2.7 Hz, 1H, H-6"), 2.92 (dd, J1 = 12.6 Hz, J2 = 5.6 
Hz, 1H, H-6"), 2.50 (s, 6H, SC6H2(CH3)3), 2.22 (s, 3H, SC6H2(CH3)3), 2.15 (m, 1H, H-2eq), 1.99 
(m, 1H, H-3'eq), 1.63 (app. q, J1 = J2 = J3 = 12.0 Hz, 1H, H-3'ax), 1.46-1.39 (m, 46H, H-2ax, 
5xCO2C(CH3)3); 13C NMR (100 MHz, CD3OD) δ 159.5, 159.3, 158.0, 157.8 (2C), 143.8 (2C), 
139.1, 132.4, 129.9 (2C), 100.4 (anomeric C), 99.3 (anomeric C), 83.9, 82.2, 80.7, 80.4, 80.2, 
77.4, 74.0, 73.5, 72.1, 66.5, 57.1, 51.7, 51.1, 50.0, 42.0, 39.2, 35.9, 35.5, 34.3, 33.1, 31.8, 30.7, 
30.5, 28.9, 28.8, 28.7, 22.5, 21.0; HRESI-MS m/z calc’d for C52H87N5O18SNa 1124.5665, found 
1124.5669 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3o. Compound 
3o was prepared as 3a using compound 2 (505 mg, 0.41 
mmol), Cs2CO3 (200 mg, 0.61 mmol), dry DMF (5 mL), and 
4-tert-butylbenzenethiol (0.344 mL, 2.04 mmol) at rt 
overnight. Completion of the reaction was observed by TLC (EtOAc:petroleum ether/3:2, Rf 
0.38). Purification by flash column chromatography (SiO2, EtOAc:petroleum ether) gave 3o (410 
mg, 90%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 7.35 (s, 4H, aromatic), 5.11 (br s, 1H, 
H-1'), 5.0 (br d, J = 2.2 Hz, 1H, H-1"), 4.07 (m, 1H, H-5"), 3.68-3.29 (m, 14H, H-1, H-3, H-4, H-
5, H-6, H-2' H-4', H-5', H-6' (2H), H-2", H-3", H-4", H-6"), 2.96 (br dd, J1 = 13.7 Hz, J2 = 7.5 
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Hz, 1H, H-6"), 2.15 (m, 1H, H-2eq), 2.03 (m, 1H, H-3'eq), 1.68 (app. q, J1 = J2 = J3 = 11.8 Hz, 
1H, H-3'ax), 1.47-1.29 (m, 55H, H-2ax, 5xCO2C(CH3)3, SC6H4(CH3)3); 13C NMR (100 MHz, 
CD3OD) δ 159.4, 159.3, 158.0, 157.8, 157.7, 150.4, 134.2, 130.4 (2C), 127.1 (2C), 100.4 
(anomeric C), 99.6 (anomeric C), 84.8, 82.3, 80.7, 80.44, 80.38, 80.2, 77.4, 73.6, 73.3, 72.0, 
72.4, 72.0, 66.5, 57.1, 51.4, 51.2, 51.0, 42.0, 35.7, 35.3, 34.4, 33.0, 31.8, 30.7, 30.4, 28.9, 28.8; 
HRESI-MS m/z calc’d for C53H89N5O18SNa 1138.5821, found 1138.5823 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3p. 
Compound 3p was prepared as 3a using compound 2 (331 
mg, 0.27 mmol), Cs2CO3 (157 mg, 0.48 mmol), dry DMF (2 
mL), and 5-tert-butyl-2-methylbenzenethiol (0.344 mL, 1.88 
mmol) at rt overnight. Completion of the reaction was observed by TLC (MeOH:CH2Cl2/0.6:9,4, 
Rf 0.44). Purification by flash column chromatography (SiO2, MeOH:CH2Cl2) gave 3p (284 mg, 
94%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 7.44 (d, J = 1.6 Hz, 1H, aromatic), 7.11 
(br dd, J1 = 8.0 Hz, J2 = 1.3 Hz, 1H, aromatic), 7.07 (br d, J = 8.0 Hz, 1H, aromatic), 5.04 (br s, 
2H, H-1', H-1"), 4.20 (m, 1H, H-5"), 3.74-3.29 (m, 14H, H-1, H-3, H-4, H-5, H-6, H-2' H-4', H-
5', H-6' (2H), H-2", H-3", H-4", H-6"), 3.06 (dd, J1 = 12.9 Hz, J2 = 6.2 Hz, 1H, H-6"), 2.33 (s, 
3H, CH3), 2.17 (m, 1H, H-2eq), 2.02 (m, 1H, H-3'eq), 1.64 (app. q, J1 = J2 = J3 = 12.1 Hz, 1H, H-
3'ax), 1.46-1.29 (m, 55H, H-2ax, 5xCO2C(CH3)3, C(CH3)3); 13C NMR (100 MHz, CD3OD) δ 
159.5, 159.3, 158.0, 157.7 (2C), 150.6, 136.6, 135.6, 130.7, 126.7, 123.9, 100.3 (anomeric C), 
99.8 (anomeric C), 84.5, 82.8, 80.7, 80.4, 80.2, 77.2, 73.7, 72.2, 72.0, 66.4, 57.1, 51.5, 51.3, 
51.1, 41.9, 36.3, 35.5, 34.3, 31.9, 31.8, 28.9, 28.8, 20.3; HRESI-MS m/z calc’d for 
C54H91N5O18SNa 1152.5978, found 1152.5970 [M+Na]+. 
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Boc-protected 6"-thioether TOB derivative 3q. 
Compound 3q was prepared as 3a using compound 2 (406 
mg, 0.33 mmol), Cs2CO3 (160 mg, 0.49 mmol), dry DMF (4 
mL), and 2-naphthalenethiol (263 mg, 1.64 mmol) at rt 
overnight. Completion of the reaction was observed by TLC (EtOAc:petroleum ether/3:2, Rf 
0.38). Purification by flash column chromatography (SiO2, EtOAc:petroleum ether) gave 3q (347 
mg, 95%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 7.85-7.77 (m, 4H, aromatic), 7.48-
7.39 (m, 3H, aromatic), 5.03 (br s, 2H, H-1', H-1"), 4.28 (m, 1H, H-5"), 3.72-3.29 (m, 14H, H-1, 
H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4", H-6"), 3.12 (br dd, J1 = 12.9 
Hz, J2 = 6.0 Hz, 1H, H-6''), 2.15-2.03 (m, 2H, H-2eq, H-3'eq), 1.69 (br app. q, J1 = J2 = J3 = 11.8 
Hz, 1H, 3'ax), 1.60-1.36 (m, 46H, H-2ax, 5xCO2C(CH3)3); 13C NMR (100 MHz, CD3OD) δ 
159.5, 159.3, 157.9, 157.7, 135.3, 133.1, 129.5, 128.7, 128.2, 127.7, 127.2, 126.6, 100.2 
(anomeric C), 99.7 (anomeric C), 84.5, 82.6, 80.7, 80.5, 80.4, 80.2, 77.3, 73.6, 73.2, 72.4, 72.0, 
66.4, 57.1, 5 51.3, 51.1, 41.9, 35.9, 35.7, 34.4, 33.1, 31.8, 30.7, 30.5, 28.9, 28.8; HRESI-MS m/z 
calc’d for C53H83N5O18SNa 1132.5352, found 1132.5354 [M+Na]+. 
 
Boc-protected 6"-thioether TOB derivative 3r. Compound 
3r was prepared as 3a using compound 2 (222 mg, 0.18 
mmol), Cs2CO3 (70 mg, 0.21 mmol), dry DMF (2 mL), and 
7-mercapto-4-methylcoumarin (104 mg, 0.54 mmol) at 55 
°C overnight. Completion of the reaction was observed by TLC (EtOAc:petroleum ether/7:3, Rf 
0.33). Purification by flash column chromatography (SiO2, EtOAc:petroleum ether) gave 3r (136 
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mg, 66%) as a white solid: 1H NMR (400 MHz, CD3OD) δ 7.66 (d, J = 8.4 Hz, 1H, coumarin 
ring), 7.36 (s, 1H, coumarin ring), 7.32 (d, J = 8.4 Hz, 1H, coumarin ring), 6.25 (s, 1H, coumarin 
ring), 5.07 (br s, 1H, H-1'), 4.89 (br s, 1H, H-1"), 4.26 (m, 1H, H-5"), 3.73-3.30 (m, 14H, H-1, 
H-3, H-4, H-5, H-6, H-2', H-4', H-5', H-6' (2H), H-2", H-3", H-4", H-6"), 3.13 (m, 1H, H-6"), 
2.25 (s, 3H, CH3 of coumarin), 2.04 (m, 2H, H-2eq, H-3'eq), 1.65 (br app. q, J1 = J2 = J3 = 11.8 
Hz, 1H, H-3'ax), 1.60-1.25 (m, 46H, H-2ax, 5xCO2C(CH3)3); 13C NMR (125 MHz, CD3OD) δ 
162.9, 159.5, 159.4, 157.9, 157.7, 155.3, 155.0, 145.2, 126.4, 124.5, 118.4, 115.1, 114.2, 99.7 
(anomeric C), 99.4 (anomeric C), 83.1, 82.3, 80.7, 80.5, 80.4, 80.2, 77.1, 73.5, 72.8, 72.4, 71.9, 
66.5, 57.1, 52.1, 51.5, 51.1, 51.0, 42.0, 35.9, 34.8, 34.3, 33.1, 30.8, 30.5, 28.9, 28.8, 18.7; 
HRESI-MS m/z calc’d for C53H83N5O20SNa 1164.5250, found 1164.5251 [M+Na]+. 
 
2.2. Synthesis of 6"-thioether TOB derivatives 4a-r. 
6"-thioether TOB derivative 4a. Compound 3a (70 mg, 0.07 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
4a (68 mg, 91%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S1) δ 5.60 (d, J = 3.5 Hz, 1H, 
H-1'), 4.94 (d, J = 3.7 Hz, 1H, H-1"), 3.89-3.77 (m, 4H, H-4, H-5', H-2", H-5"), 3.74 (app. t, J1 = 
J2 = 9.0 Hz, 1H, H-5), 3.63 (app. t, J1 = J2 = 10.1 Hz, 1H, H-6), 3.60-3.36 (m, 5H, H-1, H-3, H-
2', H-4', H-4"), 3.34-3.25 (m, 2H, H-6', H-3"), 3.11 (dd, J1 =13.6 Hz, J2 = 6.9 Hz, 1H, H-6'), 2.89 
(dd, J1 = 14.1 Hz, J2 = 2.4 Hz, 1H, H-6"), 2.62 (dd, J1 = 14.0 Hz, J2 = 7.8 Hz, 1H, H-6"), 2.47 
(app. t, J1 = J2 = 7.4 Hz, 2H, SCH2(CH2)4CH3), 2.41 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz, 1H, 
H-2eq), 2.15 (app. dt, J1 = 12.1 Hz, J2 = J3 = 4.4 Hz, 1H, H-3'eq), 1.88 (app. q, J1 = J2 = J3 = 12.2 
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Hz, 1H, H-3'ax), 1.79 (app. q, J1 = J2 = J3 = 12.8 Hz, 1H, H-2ax), 1.47-1.39 (m, 2H, 
SCH2(CH2)4CH3), 1.26-1.07 (m, 6H, SCH2(CH2)4CH3), 0.70 (t, 3H, J = 6.9 Hz, SCH2(CH2)4CH3); 
13C NMR (100 MHz, D2O) (Fig. S2) δ 162.3 (q, J = 35 Hz, CF3CO2H), 116.3 (q, J = 290 Hz, 
CF3CO2H), 100.6 (anomeric C), 94.5 (anomeric C), 83.9, 77.6, 74.2, 72.6, 70.3, 68.1, 67.9, 64.4, 
54.6, 49.1, 48.3, 47.9, 39.8, 32.4, 32.3, 30.6, 29.3, 28.7, 27.8, 27.6, 21.8, 13.3; HRESI-MS m/z 
calc’d for C24H50N5O8S 568.3380, found 568.3384 [M+H]+. 
 
6"-thioether TOB derivative 4b. Compound 3b (70 mg, 0.06 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
4b (62 mg, 83%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S3) δ 5.59 (d, J = 3.5 Hz, 1H, 
H-1'), 4.94 (d, J = 3.6 Hz, 1H, H-1"), 3.90-3.77 (m, 4H, H-4, H-5', H-2", H-5"), 3.74 (app. t, J1 = 
J2 = 9.0 Hz, 1H, H-5), 3.64 (app. t, J1 = J2 = 9.5 Hz, 1H, H-6), 3.61-3.37 (m, 5H, H-1, H-3, H-2', 
H-4', H-4"), 3.34-3.25 (m, 2H, H-6', H-3"), 3.11 (dd, J1 =13.6 Hz, J2 = 7.1 Hz, 1H, H-6'), 2.89 
(dd, J1 = 14.1 Hz, J2 = 2.2 Hz, 1H, H-6"), 2.62 (dd, J1 = 14.1 Hz, J2 = 7.8 Hz, 1H, H-6"), 2.46 
(app. t, J1 = J2 = 7.4 Hz, 2H, SCH2(CH2)6CH3), 2.41 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz, 1H, 
H-2eq), 2.15 (app. dt, J1 = 12.2 Hz, J2 = J3 = 4.3 Hz, 1H, H-3'eq), 1.88 (app. q, J1 = J2 = J3 = 12.2 
Hz, 1H, H-3'ax), 1.80 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax), 1.44 (br p, J = 7.4 Hz, 2H, 
SCH2(CH2)6CH3), 1.25-1.08 (m, 10H, SCH2(CH2)6CH3), 0.70 (t, J = 6.8 Hz, 3H, 
SCH2(CH2)6CH3); 13C NMR (125 MHz, D2O) (Fig. S4) δ 162.5 (q, J = 35 Hz, CF3CO2H), 116.0 
(q, J = 290 Hz, CF3CO2H), 100.2 (anomeric C), 94.1 (anomeric C), 83.5, 77.3, 73.8, 72.2, 69.9, 
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67.7, 67.6, 64.0, 54.3, 49.0, 47.9, 47.5, 39.4, 32.1, 31.9, 30.7, 28.9, 28.4, 27.9, 27.8, 27.5, 27.4, 
21.6, 13.0; HRESI-MS m/z calc’d for C26H54N5O8S 596.3693, found 596.3696 [M+H]+. 
 
6"-thioether TOB derivative 4c. Compound 3c (76 mg, 0.07 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
4c (74 mg, 92%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S5) δ 5.60 (d, J = 3.6 Hz, 1H, 
H-1'), 4.95 (d, J = 3.7 Hz, 1H, H-1"), 3.90-3.78 (m, 4H, H-4, H-5', H-2", H-5"), 3.75 (app. t, J1 = 
J2 = 9.1 Hz, 1H, H-5), 3.65 (app. t, J1 = J2 = 9.4 Hz, 1H, H-6), 3.61-3.37 (m, 5H, H-1, H-3, H-2', 
H-4', H-4"), 3.36-3.26 (m, 2H, H-6', H-3"), 3.11 (dd, J1 = 13.6 Hz, J2 = 7.1 Hz, 1H, H-6'), 2.90 
(dd, J1 = 14.1 Hz, J2 = 2.4 Hz, 1H, H-6"), 2.63 (dd, J1 = 14.1 Hz, J2 = 7.8 Hz, 1H, H-6"), 2.48 (t, 
J = 7.4 Hz, SCH2(CH2)8CH3), 2.41 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz, 1H, H-2eq), 2.17 (app. 
dt, J1 = 12.1 Hz, J2 = J3 = 4.4 Hz, 1H, H-3'eq), 1.89 (app. q, J1 = J2 = J3 = 12.2 Hz, 1H, H-3'ax), 
1.80 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax), 1.49-1.40 (m, 2H, SCH2(CH2)8CH3), 1.26-1.10 
(m, 14H, SCH2(CH2)8CH3), 0.71 (t, J = 7.0 Hz, 3H, SCH2(CH2)8CH3); 13C NMR (100 MHz, D2O) 
(Fig. S6) δ 162.6 (q, J = 35 Hz, CF3CO2H), 116.0 (q, J = 289 Hz, CF3CO2H), 100.3 (anomeric 
C), 94.2 (anomeric C), 83.6, 77.4, 73.9, 72.3, 70.0, 67.8, 67.7, 64.1, 54.4, 49.1, 48.0, 47.6, 39.5, 
32.2, 32.0, 30.9, 29.0, 28.5, 28.4, 28.3, 28.2, 27.9, 27.6, 21.7, 13.1; HRESI-MS m/z calc’d for 
C28H58N5O8S 624.4006, found 624.4005 [M+H]+. 
 
6"-thioether TOB derivative 4d. Compound 3d (78 mg, 0.07 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
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TFA was removed under reduced pressure, the residue was dissolved in a minimal volume of 
H2O and freeze-dried to afford 4d (79 mg, 95%) as a white foam: 1H NMR (400 MHz, D2O) 
(Fig. S7) δ 5.57 (d, J = 3.4 Hz, 1H, H-1'), 4.90 (d, J = 3.6 Hz, 1H, H-1"), 3.87-3.74 (m, 4H, H-4, 
H-5', H-2", H-5"), 3.71 (app. t, J1 = J2 = 9.0 Hz, 1H, H-5), 3.61 (app. t, J1 = J2 = 9.6 Hz, 1H, H-
6), 3.58-3.34 (m, 5H, H-1, H-3, H-2', H-4', H-4"), 3.32-3.22 (m, 2H, H-6', H-3"), 3.07 (dd, J1 = 
13.6 Hz, J2 = 7.2 Hz, 1H, H-6'), 2.86 (dd, J1 = 14.0 Hz, J2 = 2.3 Hz, 1H, H-6"), 2.58 (dd, J1 = 
14.0 Hz, J2 = 7.8 Hz, 1H, H-6"), 2.43 (t, J = 7.4 Hz, 2H, SCH2(CH2)10CH3), 2.39 (app. dt, J1 = 
12.7 Hz, J2 = J3 = 4.2 Hz, 1H, H-2eq), 2.12 (app. dt, J1 = 12.1 Hz, J2 = J3 = 4.4 Hz, 1H, H-3'eq), 
1.85 (app. q, J1 = J2 = J3 = 11.9 Hz, 1H, H-3'ax), 1.77 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax), 
1.45-1.36 (m, 2H, SCH2(CH2)10CH3), 1.22-1.05 (m, 18H, SCH2(CH2)10CH3), 0.68 (t, J = 7.0 Hz, 
3H, SCH2(CH2)10CH3);	  13C NMR (100 MHz, D2O) (Fig. S8) δ 163.3 (q, J = 35 Hz, CF3CO2H), 
116.7 (q, J = 289 Hz, CF3CO2H), 101.0 (anomeric C), 94.9 (anomeric C), 84.3, 78.0, 74.6, 73.0, 
70.7, 68.5, 68.3, 64.8, 55.0, 49.8, 48.6, 48.3, 40.2, 32.9, 32.7, 31.6, 29.7, 29.20, 29.15, 29.1, 29.0, 
28.9, 28.7, 28.3, 28.2, 22.4, 13.8; HRESI-MS m/z calc’d for C30H61N5O8SNa 674.4139, found 
674.4141 [M+Na]+. 
 
6"-thioether TOB derivative 4e. Compound 3e (52 mg, 0.04 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
4e (52 mg, 95%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S9) δ 5.57 (d, J = 3.5 Hz, 1H, 
H-1'), 4.93 (d, J = 3.7 Hz, 1H, H-1"), 3.88-3.76 (m, 4H, H-4, H-5', H-2", H-5"), 3.73 (app. t, J1 = 
J2 = 9.1 Hz, 1H, H-5), 3.62 (app. t, J1 = J2 = 9.9 Hz, 1H, H-6), 3.58-3.33 (m, 5H, H-1, H-3, H-2', 
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H-4', H-4"), 3.30 (app. t, J1 = J2 = 10.6 Hz, 1H, H-3''), 3.27 (dd, J1 = 13.6 Hz, J2 = 3.4 Hz, 1H, H-
6'), 3.10 (dd, J1 = 13.6 Hz, J2 = 7.0 Hz, 1H, H-6'), 2.89 (dd, J1 = 14.0 Hz, J2 = 2.1 Hz, 1H, H-6"), 
2.61 (dd, J1 = 14.0 Hz, J2 = 7.8 Hz, 1H, H-6"), 2.46 (t, J = 7.4 Hz, 2H, SCH2(CH2)12CH3), 2.38 
(app. dt, J1 = 12.5 Hz, J2 = J3 = 4.1 Hz, 1H, H-2eq), 2.14 (app. dt, J1 = 12.1 Hz, J2 = J3 = 4.3 Hz, 
1H, H-3'eq), 1.86 (app. q, J1 = J2 = J3 = 12.0 Hz, 1H, H-3'ax), 1.76 (app. q, J1 = J2 = J3 = 12.6 Hz, 
1H, H-2ax), 1.47-1.38 (m, 2H, SCH2(CH2)12CH3), 1.24-1.08 (m, 22H, SCH2(CH2)12CH3), 0.69 (t, 
J = 6.7 Hz, 3H, SCH2(CH2)12CH3); 13C NMR (100 MHz, D2O) (Fig. S10) δ 162.6 (q, J = 35 Hz, 
CF3CO2H), 116.0 (q, J = 290 Hz, CF3CO2H), 100.3 (anomeric C), 94.3 (anomeric C), 83.7, 77.6, 
74.0, 72.3, 70.0, 67.8, 67.7, 64.1, 54.4, 49.2, 48.0, 47.6, 39.5, 32.2, 32.1, 30.9, 29.1, 28.53, 28.46, 
28.40, 28.3, 28.2, 28.0, 27.7, 27.6, 21.7, 13.1; HRESI-MS m/z calc’d for C32H65N5NaO8S 
702.4452, found 702.4453 [M+Na]+. 
 
6"-thioether TOB derivative 4f. Compound 3f (34 mg, 0.03 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
4f (35 mg, 98%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S11) δ 5.58 (d, J = 3.4 Hz, 1H, 
H-1'), 4.93 (d, J = 3.6 Hz, 1H, H-1"), 3.87-3.76 (m, 4H, H-4, H-5', H-2", H-5"), 3.73 (app. t, J1 = 
J2 = 9.1 Hz, 1H, H-5), 3.63 (app. t, J1 = J2 = 9.7 Hz, 1H, H-6), 3.59-3.31 (m, 5H, H-1, H-3, H-2', 
H-4', H-4"), 3.30 (app. t, J1 = J2 = 10.6 Hz, 1H, H-3"), 3.28 (dd, J1 = 13.5 Hz, J2 = 3.5 Hz, 1H, H-
6'), 3.09 (dd, J1 = 13.5 Hz, J2 = 7.0 Hz, 1H, H-6'), 2.89 (dd, J1 = 14.0 Hz, J2 = 2.1 Hz, 1H, H-6"), 
2.60 (dd, J1 = 14.0 Hz, J2 = 7.8 Hz, 1H, H-6"), 2.45 (t, J = 7.3 Hz, 2H, SCH2(CH2)14CH3), 2.39 
(app. dt, J1 = 12.6 Hz, J2 = J3 = 4.1 Hz, 1H, H-2eq), 2.15 (app. dt, J1 = 12.1 Hz, J2 = J3 = 4.4 Hz, 
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1H, H-3'eq), 1.86 (app. q, J1 = J2 = J3 = 11.9 Hz, 1H, H-3'ax), 1.76 (app. q, J1 = J2 = J3 = 12.6 Hz, 
1H, H-2ax), 1.47-1.38 (m, 2H, SCH2(CH2)14CH3), 1.24-1.05 (m, 26H, SCH2(CH2)14CH3), 0.70 (t, 
J = 6.3 Hz, 3H, SCH2(CH2)14CH3); 13C NMR (100 MHz, D2O) (Fig. S12) δ 162.6 (q, J = 35 Hz, 
CF3CO2H), 116.0 (q, J = 290 Hz, CF3CO2H), 100.3 (anomeric C), 94.2 (anomeric C), 83.6, 77.4, 
73.9, 72.3, 70.0, 67.8, 67.6, 64.1, 54.3, 49.1, 48.0, 47.6, 39.5, 32.2, 32.1, 30.9, 29.0, 28.5, 28.4, 
28.3, 28.1, 28.0, 27.7, 27.5, 21.8, 13.1; HRESI-MS m/z calc’d for C34H70N5O8S 708.4945, found 
708.4948 [M+H]+. 
 
6"-thioether TOB derivative 4g. Compound 3g (37 mg, 0.03 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
4g (38 mg, 96%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S13) δ 5.58 (d, J = 3.1 Hz, 
1H, H-1'), 4.87 (d, J = 3.0 Hz, 1H, H-1"), 3.85-3.73 (m, 4H, H-4, H-5', H-2", H-5"), 3.70 (app. t, 
J1 = J2 = 9.0 Hz, 1H, H-5), 3.59 (app. t, J1 = J2 = 9.2 Hz, 1H, H-6), 3.49-3.31 (m, 5H, H-1, H-3, 
H-2', H-4', H-4"), 3.31-3.24 (m, 2H, H-6', H-3"), 2.98 (br dd, J1 = 12.2 Hz, J2 = 7.9 Hz, 1H, H-
6'), 2.85 (br d, J1 = 12.1 Hz, 1H, H-6"), 2.52 (br dd, J1 = 13.4 Hz, J2 = 6.9 Hz, 1H, H-6"), 2.37 
(m, 3H, H-2eq, SCH2(CH2)16CH3), 2.11 (m, 1H, H-3'eq), 1.84 (app. q, J1 = J2 = J3 = 11.5 Hz, 1H, 
H-3'ax), 1.77 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax), 1.37 (m, 2H, SCH2(CH2)16CH3), 1.19-
1.05 (m, 30H, SCH2(CH2)16CH3), 0.69 (t, J = 6.8 Hz, 3H, SCH2(CH2)16CH3); 13C NMR (125 
MHz, D2O) (Fig. S14) δ 162.4 (q, J = 35 Hz, CF3CO2H), 116.0 (q, J = 290 Hz, CF3CO2H), 100.2 
(anomeric C), 93.8 (anomeric C), 83.6, 77.2, 73.9, 72.5, 69.9, 67.8, 67.7, 64.4, 54.5, 49.1, 48.0, 
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47.6, 39.8, 32.6, 32.2, 31.4, 29.2, 29.0, 28.8, 28.6, 28.1, 27.6, 22.1, 13.4; HRESI-MS m/z calc’d 
for C36H74N5O8S 736.5258, found 736.5259 [M+H]+ 
 
6"-thioether TOB derivative 4h. Compound 3h (98 mg, 0.08 
mmol) was treated at rt with 95% TFA (1.5 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
4h (76 mg, 74%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S15) δ δ 5.61 (d, J = 2.8 Hz, 
1H, H-1'), 4.87 (d, J = 2.6 Hz, 1H, H-1"), 3.89-3.73 (m, 4H, H-4, H-5', H-2", H-5"), 3.72 (app. t, 
J1 = J2 = 9.0 Hz, 1H, H-5), 3.61 (app. t, J1 = J2 = 9.4 Hz, 1H, H-6), 3.49-3.34 (m, 5H, H-1, H-3, 
H-2', H-4', H-4"), 3.33-3.26 (m, 2H, H-6', H-3"), 2.96 (br dd, J1 = 13.3 Hz, J2 = 8.2 Hz, 1H, H-
6'), 2.86 (br d, J1 = 12.1 Hz, 1H, H-6"), 2.51 (br dd, J1 = 13.3 Hz, J2 = 6.8 Hz, 1H, H-6"), 2.39 
(m, 3H, H-2eq, SCH2(CH2)20CH3), 2.12 (m, 1H, H-3'eq), 1.89-1.79 (m, 2H, H-2ax, H-3'ax), 1.37 
(m, 2H, SCH2(CH2)20CH3), 1.15-1.07 (m, 38H, SCH2(CH2)20CH3), 0.72 (t, J = 6.6 Hz, 3H, 
SCH2(CH2)20CH3); 13C NMR (100 MHz, D2O) (Fig. S16) δ 162.4 (q, J = 35 Hz, CF3CO2H), 
116.0 (q, J = 290 Hz, CF3CO2H), 100.1 (anomeric C), 93.6 (anomeric C), 83.4, 76.8, 73.8, 72.5, 
70.2, 67.8, 67.7, 64.5, 54.5, 49.0, 48.0, 47.5, 39.8, 32.7, 32.4, 31.6, 29.4, 29.2, 29.1, 28.8, 28.3, 
27.4, 22.2, 13.5; HRESI-MS m/z calc’d for C40H81N5O8SNa 814.5704, found 814.5706 [M+Na]+. 
 
6"-thioether TOB derivative 4i. Compound 3i (41 mg, 0.06 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
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4i (41 mg, 94%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S17) δ 5.57 (d, J = 3.4 Hz, 1H, 
H-1'), 4.92 (d, J = 3.6 Hz, 1H, H-1"), 3.89-3.77 (m, 4H, H-4, H-5', H-2", H-5"), 3.73 (app. t, J1 = 
J2 = 9.0 Hz, 1H, H-5), 3.63 (app. t, J1 = J2 = 10.2 Hz, 1H, H-6), 3.58-3.34 (m, 5H, H-1, H-3, H-2', 
H-4', H-4"), 3.31 (app. t, J1 = J2 = 10.6 Hz, 1H, H-3"), 3.27 (dd, J1 = 13.6 Hz, J2 = 3.3 Hz, 1H, H-
6'), 3.13 (dd, J1 = 13.6 Hz, J2 = 6.9 Hz, 1H, H-6'), 2.93 (dd J1 = 13.0 Hz, J2 = 2.0 Hz, 1H, H-6"), 
2.67 (dd, J1 = 13.2 Hz, J2 = 8.0 Hz, 1H, H-6"), 2.41 (app. dt, J1 = 11.4 Hz, J2 = J3 = 4.1 Hz, 1H, 
H-2eq), 2.16 (app. dt, J1 =12.3 Hz, J2 = J3 = 4.1 Hz, 1H, H-3'eq), 1.88 (app. q, J1 = J2 = J3 = 12.6 
Hz, 1H, H-3'ax), 1.79 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax), 1.18 (s, 9H, SC(CH3)3); 13C 
NMR (100 MHz, D2O) (Fig. S18) δ 162.3 (q, J = 35 Hz, CF3CO2H), 115.5 (q, J = 290 Hz, 
CF3CO2H), 100.1 (anomeric C), 94.1 (anomeric C), 83.4, 77.2, 73.6, 72.2, 69.9, 67.9, 67.4, 63.8, 
54.1, 48.9, 47.8, 47.4, 42.3, 39.2, 29.4, 28.7, 28.4, 27.3; HRESI-MS m/z calc’d for C22H46N5O8S 
540.3067, found 540.3068 [M+H]+. 
 
6"-thioether TOB derivative 4j. Compound 3j (53 mg, 0.05 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to 
afford 4j (52 mg, 92%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S19) δ 5.54 (d, J = 3.3 
Hz, 1H, H-1'), 4.89 (d, J = 3.5 Hz, 1H, H-1"), 3.86-3.73 (m, 4H, H-4, H-5', H-2", H-5"), 3.69 
(app. t, J1 = J2 = 9.1 Hz, 1H, H-5), 3.59 (app. t, J1 = J2 = 10.1 Hz, 1H, H-6), 3.55-3.33 (m, 5H, H-
3, H-1, H-2', H-4', H-4"), 3.26 (app. t, J1 = J2 = 10.6 Hz, 1H, H-3"), 3.23 (dd, J1 = 13.4 Hz, J2 = 
3.3 Hz, 1H, H-6'), 3.07 (dd, J1 = 13.6 Hz, J2 = 7.1 Hz, 1H, H-6'), 2.89 (dd, J1 = 13.8 Hz, J2 = 2.0 
Hz, 1H, H-6"), 2.63-2.57 (m, 2H, H-6", SC6H11), 2.37 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.0 Hz, 1H, 
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H-2eq), 2.11 (app. dt, J1 = 12.2 Hz, J2 = J3 = 4.3 Hz, 1H, H-3'eq), 1.84 (app. q, J1 = J2 = J3 = 12.0 
Hz, 1H, H-3'ax), 1.80-1.71 (m, 3H, H-2ax, SC6H11), 1.57-1.49 (m, 2H, SC6H11), 1.44-1.36 (m, 
1H, SC6H11), 1.17-0.97 (m, 5H, SC6H11); 13C NMR (125 MHz, D2O) (Fig. S20) δ 162.7 (q, J = 35 
Hz, CF3CO2H), 116.0 (q, J = 290 Hz, CF3CO2H), 100.4 (anomeric C), 94.3 (anomeric C), 83.7, 
77.3, 73.9, 72.3, 70.2, 67.9, 67.7, 64.1, 54.4, 49.2, 48.0, 47.7, 44.2, 39.5, 33.1, 32.9, 30.2, 29.0, 
27.5, 25.4, 25.3, 24.9; HRESI-MS m/z calc’d for C24H48N5O8S 566.3224, found 566.3226 
[M+H]+. 
 
6"-thioether TOB derivative 4k. Compound 3k (45 mg, 0.04 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 
4k (40 mg, 83%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S21) δ 7.27 (d, J = 7.5 Hz, 
2H, aromatic), 7.20 (dd, J1 = J2 = 7.5 Hz, 2H, aromatic), 7.12 (t, J = 7.4 Hz, 1H, aromatic), 5.54 
(d, J = 3.5 Hz, 1H, H-1'), 4.92 (d, J = 3.6 Hz, 1H, H-1"), 3.94 (ddd, J1 = 9.7 Hz, J2 = 8.0 Hz, J3 = 
2.2 Hz, 1H, H-5"), 3.87-3.79 (m, 2H, H-4, H-2"), 3.77 (ddd, J1 = 9.0 Hz, J2 = 7.5 Hz, J3 = 3.6 Hz, 
1H, H-5'), 3.68 (app. t, J1 = J2 = 9.0 Hz, 1H, H-5), 3.61 (app. t, J1 = J2 = 9.8 Hz, 1H, H-6), 3.58-
3.51 (m, 2H, H-4', H-4"), 3.48 (app. dt, J1 = 11.8 Hz, J2 = J3 = 3.9 Hz, 1H, H-2'), 3.44-3.32 (m, 
3H, H-1, H-3, H-6"), 3.30 (app. t, J1 = J2 = 10.6 Hz, 1H, H-3"), 3.24 (dd, J1 = 13.6 Hz, J2 = 3.4 
Hz, 1H, H-6'), 3.08 (dd, J1 = 13.5 Hz, J2 = 7.2 Hz, 1H, H-6'), 3.02 (dd, J1 = 14.2 Hz, J2 = 7.8 Hz, 
1H, H-6"), 2.38 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz, 1H, H-2eq), 2.10 (app. dt, J1 = 12.2 Hz, 
J2 = J3 = 4.4 Hz, 1H, H-3'eq), 1.84 (app. q, J1 = J2 = J3 = 12.0 Hz, 1H, H-3'ax), 1.77 (app. q, J1 = 
J2 = J3 = 11.6 Hz, 1H, H-2ax); 13C NMR (100 MHz, D2O) (Fig. S22) δ 162.5 (q, J = 35 Hz, 
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CF3CO2H), 134.9, 129.2 (2C), 128.7 (2C), 126.6, 116.0 (q, J = 290 Hz, CF3CO2H), 100.4 
(anomeric C), 94.0 (anomeric C), 83.5, 77.2, 74.0, 72.0, 70.2, 67.9, 67.7, 64.1, 54.3, 49.2, 48.0, 
47.6, 39.5, 34.6, 29.0, 27.5; HRESI-MS m/z calc’d for C24H41N5O8SNa 582.2574, found 
582.2575 [M+Na]+. 
 
6"-thioether TOB derivative 4l. Compound 3l (42 mg, 0.04 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to 
afford 4l (42 mg, 95%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S23) δ 7.19 (d, J = 8.1 
Hz, 2H, aromatic), 7.20 (app. t, J1 = J2 = 7.5 Hz, 2H, aromatic), 5.53 (d, J = 3.5 Hz, 1H, H-1'), 
4.92 (d, J = 3.6 Hz, 1H, H-1"), 3.93 (ddd, J1 = 9.5 Hz, J2 = 8.0 Hz, J3 = 2.4 Hz, 1H, H-5"), 3.86-
3.79 (m, 2H, H-4, H-2"), 3.76 (m, 1H, H-5'), 3.69 (app. t, J1 = J2 = 9.0 Hz, 1H, H-5), 3.61 (app. t, 
J1 = J2 = 9.9 Hz, 1H, H-6), 3.58-3.51 (m, 2H, H-4', H-4"), 3.48 (m, 1H, H-2'), 3.45-3.32 (m, 2H, 
H-1, H-3), 3.31-3.21 (m, 3H, H-6', H-3", H-6"), 3.08 (dd, J1 = 13.6 Hz, J2 = 7.0 Hz, 1H, H-6'), 
2.99 (dd, J1 = 14.1 Hz, J2 = 7.8 Hz, 1H, H-6"), 2.38 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz, 1H, 
H-2eq), 2.13 (s, 3H, SC6H4CH3), 2.10 (app. dt, J1 = 11.9 Hz, J2 = J3 = 4.0 Hz, 1H, H-3'eq), 1.83 
(app. q, J1 = J2 = J3 = 11.9 Hz, 1H, H-3'ax), 1.77 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax); 13C 
NMR (125 MHz, D2O) (Fig. S24) δ 162.7 (q, J = 35 Hz, CF3CO2H), 137.5, 131.1, 129.9 (2C), 
129.6 (2C), 116.1 (q, J = 290 Hz, CF3CO2H), 100.4 (anomeric C), 94.3 (anomeric C), 83.6, 77.4, 
74.1, 72.2, 70.2, 67.9, 67.7, 64.1, 54.4, 49.2, 48.0, 47.7, 39.5, 35.5, 29.0, 27.5, 19.8; ESI-MS m/z 
calc’d for C25H44N5O8S 574.2911, found 574.2910 [M+H]+. 
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6"-thioether TOB derivative 4m. Compound 3m (71 mg, 0.06 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 4m (65 mg, 86%) as a white 
foam: 1H NMR (400 MHz, D2O) (Fig. S25) δ 7.05 (m, 3H, aromatic), 5.54 (d, J = 3.5 Hz, 1H, H-
1'), 4.90 (d, J = 3.6 Hz, 1H, H-1"), 3.96 (ddd, J1 = 9.2 Hz, J2 = 6.0 Hz, J3 = 3.0 Hz, 1H, H-5"), 
3.85-3.79 (m, 2H, H-4, H-2"), 3.75 (m, 1H, H-5'), 3.70 (app. t, J1 = J2 = 9.1 Hz, 1H, H-5), 3.62-
3.57 (m, 2H, H-6, H-4"), 3.55 (m, 1H, H-4'), 3.47 (app. dt, J1 = 11.7 Hz, J2 = J3 = 3.8 Hz, 1H, H-
2'), 3.43-3.33 (m, 2H, H-1, H-3), 3.29 (app. t, J1 = J2 = 10.6 Hz, 1H, H-3"), 3.23 (dd, J1 = 13.6 
Hz, J2 = 3.5 Hz, 1H, H-6'), 3.08 (dd, J1 = 13.6 Hz, J2 = 7.0 Hz, 1H, H-6'), 2.91 (dd, J1 = 13.5 Hz, 
J2 = 6.3 Hz, 1H, H-6"), 2.85 (dd, J1 = 13.4 Hz, J2 = 3.0 Hz, 1H, H-6"), 2.38 (m, 1H, H-2eq), 2.35 
(s, 6H, SC6H3(CH3)2), 2.09 (app. dt, J1 = 12.2 Hz, J2 = J3 = 4.1 Hz, 1H, H-3'eq), 1.83 (app. q, J1 = 
J2 = J3 = 11.9 Hz, 1H, H-3'ax), 1.75 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax); 13C NMR (125 
MHz, D2O) (Fig. S26) δ 162.5 (q, J = 35 Hz, CF3CO2H), 142.5, 132.3, 128.5, 127.8 (2C), 116.0 
(q, J = 290 Hz, CF3CO2H), 100.3, 93.9, 83.2, 77.1, 73.8, 71.9, 69.9, 67.5, 67.3, 63.8, 54.2, 49.0, 
47.8, 47.3, 39.2, 35.6, 28.7, 27.3, 20.7 (2C); HRESI-MS m/z calc’d for C26H46N5O8S 588.3067, 
found 588.3063 [M+H]+. 
 
6"-thioether TOB derivative 4n. Compound 3n (53 mg, 0.05 
mmol) was treated at rt with 95% TFA (1 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to 
afford 4n (55 mg, 98%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S27) δ 6.90 (s, 2H, 
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aromatic), 5.56 (d, J = 3.6 Hz, 1H, H-1'), 4.90 (d, J = 3.7 Hz, 1H, H-1"), 3.96 (ddd, J1 = 9.4 Hz, 
J2 = 6.2 Hz, J3 = 3.2 Hz, 1H, H-5"), 3.87-3.82 (m, 2H, H-4, H-2"), 3.77 (ddd, J1 = 8.8 Hz, J2 = 
7.1 Hz, J3 = 3.6 Hz, 1H, H-5'), 3.72 (app. t, J1 = J2 = 9.0 Hz, 1H, H-5), 3.65-3.53 (m, 3H, H-6, H-
4', H-4"), 3.49 (app. dt, J1 = 11.4 Hz, J2 = J3 = 4.0 Hz, 1H, H-2'), 3.45-3.36 (m, 2H, H-1, H-3), 
3.32 (app. t, J1 = J2 = 10.6 Hz, 1H, H-3"), 3.25 (dd, J1 = 13.6 Hz, J2 = 3.6 Hz, 1H, H-6'), 3.10 (dd, 
J1 = 13.6 Hz, J2 = 7.0 Hz, 1H, H-6'), 2.89 (dd, J1 = 13.4 Hz, J2 = 6.3 Hz, 1H, H-6"), 2.83 (dd, J1 = 
13.4 Hz, J2 = 3.3 Hz, 1H, H-6"), 2.40 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz 1H, H-2eq), 2.32 (s, 
6H, SC6H2(CH3)3), 2.11 (ddd, J1 = 12.2 Hz, J2 = 8.8 Hz, J3 = 4.4 Hz, 1H, H-3'eq), 2.08 (s, 3H, 
SC6H2(CH3)3), 1.85 (app. q, J1 = J2 = J3 = 12.1 Hz, 1H, H-3'ax), 1.80 (app. q, J1 = J2 = J3 = 12.6 
Hz, 1H, H-2ax); 13C NMR (100 MHz, D2O) (Fig. S28) δ 162.5 (q, J = 35 Hz, CF3CO2H), 142.9, 
139.6, 129.3, 129.0 (2C), 116.0 (q, J = 290 Hz, CF3CO2H), 100.8, 94.3, 83.7, 77.5, 74.2, 72.4, 
70.4, 68.0, 67.8, 64.3, 54.7, 49.6, 48.3, 47.8, 39.7, 36.2, 29.2, 27.8, 21.1, 19.9; HRESI-MS m/z 
calc’d for C27H48N5O8S 602.3224, found 602.3227 [M+H]+. 
 
6"-thioether TOB derivative 4o. Compound 3o (79 mg, 
0.07 mmol) was treated at rt with 95% TFA (1 mL) for 3 
min. The TFA was removed under reduced pressure, the 
residue was dissolved in a minimal volume of H2O and 
freeze-dried to afford 4o (73 mg, 84%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S29) δ 
7.30 (d, J = 8.5 Hz, 2H, aromatic), 7.24 (d, J = 8.4 Hz, 2H, aromatic), 5.54 (d, J = 3.5 Hz, 1H, H-
1'), 4.92 (d, J = 3.6 Hz, 1H, H-1"), 3.93 (ddd, J1 = 9.7 Hz, J2 = 7.9 Hz, J3 = 2.2 Hz, 1H, H-5"), 
3.86-3.80 (m, 2H, H-4, H-2"), 3.76 (ddd, J1 = 9.2 Hz, J2 = 7.2 Hz, J3 = 3.6 Hz, 1H, H-5'), 3.70 
(app. t, J1 = J2 = 9.1 Hz, 1H, H-5), 3.61 (app. t, J1 = J2 = 9.2 Hz, 1H, H-6), 3.58-3.51 (m, 2H, H-
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4', H-4"), 3.47 (app. dt, J1 = 11.9 Hz, J2 = J3 = 4.0 Hz, 1H, H-2'), 3.44-3.33 (m, 3H, H-1, H-3, H-
6"), 3.32-3.26 (m, 2H, H-3", H-6"), 3.23 (dd, J1 = 13.6 Hz, J2 = 3.5 Hz, 1H, H-6'), 3.08 (dd, J1 = 
13.6 Hz, J2 = 7.1 Hz, 1H, H-6'), 3.00 (dd, J1 = 14.0 Hz, J2 = 7.8 Hz, 1H, H-6"), 2.37 (app. dt, J1 = 
12.6 Hz, J2 = J3 = 4.2 Hz, 1H, H-2eq), 2.10 (app. dt, J1 = 12.2 Hz, J2 = J3 = 4.3Hz, 1H, H-3'eq), 
1.83 (app. q, J1 = J2 = J3 = 12.0 Hz, 1H, H-3'ax), 1.77 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax), 
1.10 (s, 9H, SC6H4(CH3)3); 13C NMR (100 MHz, D2O) (Fig. S30) δ 162.5 (q, J = 35 Hz, 
CF3CO2H), 151.0, 131.7, 129.5 (2C), 126.6 (2C), 116.3 (q, J = 290 Hz, CF3CO2H), 100.7 
(anomeric C), 94.5 (anomeric C), 83.8, 77.6, 74.2, 72.4, 70.4, 68.1, 67.9, 64.3, 54.6, 49.4, 48.2, 
47.9, 39.7, 35.5, 33.9, 30.3 (3C), 29.2, 27.7; HRESI-MS m/z calc’d for C28H50N5O8S 616.3380, 
found 616.3381 [M+H]+. 
 
6"-thioether TOB derivative 4p. Compound 3p (26 mg, 
0.02 mmol) was treated at rt with 95% TFA (1 mL) for 3 
min. The TFA was removed under reduced pressure, the 
residue was dissolved in a minimal volume of H2O and 
freeze-dried to afford 4p (26 mg, 94%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S31) δ 
7.40 (d, J = 4.1 Hz, 1H, aromatic), 7.19 (dd, J1 = 7.9 Hz, J2 = 1.8 Hz, 1H, aromatic), 7.11 (d, J = 
8.0 Hz, 1H, aromatic), 5.60 (d, J = 3.5 Hz, 1H, H-1'), 4.95 (d, J = 3.6 Hz, 1H, H-1"), 4.01 (ddd, 
J1 = 9.5 Hz, J2 = 7.1 Hz, J3 = 2.4 Hz, 1H, H-5"), 3.90-3.84 (m, 2H, H-4, H-2"), 3.80 (ddd, J1 = 
12.1 Hz, J2 = 8.2 Hz, J3 = 3.6 Hz, 1H, H-5'), 3.72 (app. t, J1 = J2 = 9.0 Hz, 1H, H-5), 3.68-3.57 
(m, 3H, H-6, H-4', H-4"), 3.52 (app. dt, J1 = 11.6 Hz, J2 = J3 = 3.9 Hz, 1H, H-2'), 3.49-3.25 (m, 
5H, H-1, H-3, H-6', H-3", H-6"), 3.13 (dd, J1 = 13.7 Hz, J2 = 7.2 Hz, 1H, H-6"), 3.08 (dd, J1 = 
13.6 Hz, J2 = 6.9 Hz, 1H, H-6'), 2.42 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.0 Hz, 1H, H-2eq), 2.21 (s, 
O
NH2
HO
H2N O
NH2
NH2
O
HO
O
OH
H2N
HO
S
	   29 
3H, CH3), 2.15 (app. dt, J1 = 12.3 Hz, J2 = J3 = 4.0 Hz, 1H, H-3'eq), 1.88 (app. q, J1 = J2 = J3 = 
11.9 Hz, 1H, H-3'ax), 1.80 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax), 1.15 (s, 9H, C(CH3)3); 13C 
NMR (100 MHz, D2O) (Fig. S32) δ 162.8 (q, J = 35 Hz, CF3CO2H), 150.5, 135.3, 134.1, 130.2, 
126.1, 124.0, 116.3 (q, J = 290 Hz, CF3CO2H), 100.8 (anomeric C), 94.1 (anomeric C), 83.8, 
77.2, 74.1, 72.3, 70.6, 67.9, 64.2, 54.6, 49.6, 48.3, 47.8, 39.7, 34.4, 34.0, 30.4, 29.2, 27.7, 19.0; 
HRESI-MS m/z calc’d for C29H52N5O8S 630.3537, found 630.3534 [M+H]+. 
 
6"-thioether TOB derivative 4q. Compound 3q (53 mg, 
0.05 mmol) was treated at rt with 95% TFA (1 mL) for 3 
min. The TFA was removed under reduced pressure, the 
residue was dissolved in a minimal volume of H2O and 
freeze-dried to afford 4q (55 mg, 97%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S33) δ 
7.78-7.70 (m, 4H, aromatic), 7.45-7.37 (m, 3H, aromatic), 5.48 (d, J = 3.5 Hz, 1H, H-1'), 4.94 (d, 
J = 3.7 Hz, 1H, H-1"), 4.05 (ddd, J1 = 9.8 Hz, J2 = 7.8 Hz, J3 = 2.4 Hz, 1H, H-5"), 3.86 (dd, J1 = 
10.8 Hz, J2 = 3.6 Hz, 1H, H-2"), 3.84-3.79 (m, 1H, H-4), 3.75 (ddd, J1 = 8.8 Hz, J2 = 7.2 Hz, J3 = 
3.5 Hz, 1H, H-5'), 3.69 (app. t, J1 = J2 = 8.9 Hz, 1H, H-5), 3.63-3.52 (m, 3H, H-6, H-4', H-4"), 
3.50 (dd, J1 = 14.2 Hz, J2 = 2.4 Hz, 1H, H-6"), 3.45-3.32 (m, 4H, H-1, H-3, H-2', H-3"), 3.25 (dd, 
J1 = 13.6 Hz, J2 = 3.5 Hz, 1H, H-6'), 3.17 (dd, J1 = 14.2 Hz, J2 = 7.7 Hz, 1H, H-6"), 3.07 (dd, J1 = 
13.6 Hz, J2 = 7.2 Hz, 1H, H-6'), 2.38 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz, 1H, H-2eq), 2.10 
(app. dt, J1 = 12.2 Hz, J2 = J3 = 4.3 Hz, 1H, H-3'eq), 1.82 (m, 1H, H-3'ax), 1.76 (app. q, J1 = J2 = 
J3 = 12.6 Hz, 1H, H-2ax); 13C NMR (100 MHz, D2O) (Fig. S34) δ 162.7 (q, J = 35 Hz, 
CF3CO2H), 133.2, 132.8, 131.3, 128.6, 127.5, 126.9, 126.7, 126.5, 126.1, 115.5 (q, J = 290 Hz, 
CF3CO2H), 100.4 (anomeric C), 93.9 (anomeric C), 83.4, 77.0, 74.0, 72.1, 70.2, 68.0, 67.7, 64.1, 
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54.4, 49.2, 48.1, 47.5, 39.5, 34.3, 29.0, 27.5; HRESI-MS m/z calc’d for C28H44N5O10S 610.2911, 
found 610.2912 [M+H]+. 
 
6"-thioether TOB derivative 4r. Compound 3r (37 mg, 
0.03 mmol) was treated at rt with 95% TFA (1 mL) for 3 
min. The TFA was removed under reduced pressure, the 
residue was dissolved in a minimal volume of H2O and 
freeze-dried to afford 4r (36 mg, 93%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S35) δ 
7.52 (d, J = 8.5 Hz, 1H, coumarin ring), 7.26 (d, J = 1.6 Hz, 1H, coumarin ring), 7.20 (dd, J1 = 
8.4 Hz, J2 = 1.5 Hz, 1H, coumarin ring), 6.16 (s, 1H, coumarin ring), 5.59 (d, J = 3.5 Hz, 1H, H-
1'), 4.86 (d, J = 3.6 Hz, 1H, H-1"), 4.01 (ddd, J1 = 9.4 Hz, J2 = 6.8 Hz, J3 = 2.8 Hz, 1H, H-5"), 
3.84-3.78 (m, 2H, H-4, H-2"), 3.74 (m, 1H, H-5'), 3.67 (app. t, J1 = J2 = 9.1 Hz, 1H, H-5), 3.63-
3.52 (m, 4H, H-6, H-2', H-4', H-4"), 3.46 (dd, J1 = 14.8 Hz, J2 = 2.7 Hz, 1H, H-6"), 3.43-3.29 (m, 
3H, H-1, H-3, H-3"), 3.25 (dd, J1 = 13.8 Hz, J2 = 3.5 Hz, H-6"), 3.18 (dd, J1 = 14.6 Hz, J2 = 6.6 
Hz, 1H, H-6'), 3.08 (dd, J1 = 13.7 Hz, J2 = 7.1 Hz, 1H, H-6'), 2.36 (app. dt, J1 = 12.6 Hz, J2 = J3 = 
4.1 Hz, 1H, H-2eq), 2.28 (s, 3H, CH3, coumarin ring), 2.14 (app. dt, J1 = 12.3 HZ, J2 = J3 = 4.0 
Hz, 1H, H-3'eq), 1.85 (app. q, J1 = J2 = J3 = 12.1 Hz, 1H, H-3'ax), 1.74 (app. q, J1 = J2 = J3 = 12.6 
Hz, 1H, H-2ax); 13C NMR (125 MHz, D2O) (Fig. S36) δ 163.7, 162.8 (q, J = 35 Hz, CF3CO2H), 
155.8, 152.5, 141.8, 125.1, 123.2, 117.4, 115.5 (q, J = 290 Hz, CF3CO2H), 113.9, 112.1, 100.5 
(anomeric C), 93.7 (anomeric C), 83.4, 76.6, 74.0, 71.8, 70.1, 67.6, 67.4, 63.9, 54.2, 49.1, 47.9, 
47.4, 39.4, 32.6, 28.9, 27.3, 17.5; HRESI-MS m/z calc’d for C28H44N5O10S 642.2809, found 
642.2804 [M+H]+. 
 
O
NH2
HO
H2N O
NH2
NH2
O
HO
O
OH
H2N
HO
S
O
O
	   31 
2.3. Oxidation of 6"-thioether TOB derivatives 3d-e into 6"-sulfoxide TOB derivatives 5d-e. 
6"-sulfoxide TOB derivative 5d. Compound 3d (61 mg, 0.05 
mmol) dissolved in CHCl3 (1.5 mL) was treated with m-
chloroperbenzoic acid (70-75%) (12 mg, ~0.07 mmol). The 
reaction mixture was stirred at rt and progress of the reaction was 
monitored by ESI-MS by following the disappearance of the starting material ([M+H]+, m/z 
1153.20) and the formation of the corresponding sulfoxide ([M+H]+, m/z 1169.19). Upon 
completion, the reaction mixture was diluted with CHCl3 (10 mL), washed with 1 M KOH (2 
mL), concentrated under reduced pressure, and treated with 95% TFA (0.4 mL) for 3 min. The 
TFA was removed under reduced pressure, the residue was dissolved in a minimal volume of 
H2O and freeze-dried to afford 5d (34 mg, 55%) as a white foam. (Note: A mixture of 2 
diastereomers (~4:1 ratio) was obtained. The major and minor diastereomers are designated as (i) 
and (ii), respectively): 1H NMR (400 MHz, D2O) (Fig. S37) δ 5.69 (d, J = 3.5 Hz, 1H, H-1'(i)), 
5.63 (d, J = 3.5 Hz, 1H, H-1'(ii)), 4.96 (d, J = 3.6 Hz, 1H, H-1"(ii)), 4.95 (d, J = 3.6 Hz, 1H, H-
1"(i)), 4.26 (app. td, J1 = J2 = 9.2 Hz, J3 = 2.2 Hz, 1H, H-5"(i)), 4.09 (app. td, J1 = J2 = 9.7 Hz, J3 = 
2.4 Hz, 1H, H-5"(ii)), 3.89-3.69 (m, 8H, H-4(i), H-4(ii), H-5(i), H-5(ii), H-5'(i), H-5'(ii), H-2"(i), H-
2"(ii)), 3.65-3.35 (m, 14H, H-1(i), H-1(ii), H-3(i), H-3(ii), H-6(i), H-6(ii), H-2'(i), H-2'(ii), H-4'(i), H-
4'(ii), H-3"(i), H-3"(ii), H-4"(i), H-4"(ii)), 3.31-3.24 (m, 3H, H-6'(i), H-6"(i), H-6"(ii)), 3.20 (dd, J1 = 
13.7 Hz, J2 = 2.4 Hz, 1H, H-6'(ii)), 3.10 (dd, J1 = 13.6 Hz, J2 = 7.1 Hz, 2H, H-6'(i), H-6'(ii)), 2.97-
2.88 (m, 6H, H-6"(i), H-6"(ii), SCH2(CH2)10CH3(i), SCH2(CH2)10CH3(ii)), 2.41 (app. dt, J1 = 12.6 Hz, 
J2 = J3 = 4.2 Hz, 2H, H-2eq(i), H-2eq(ii)), 2.15 (app. dt, J1 = 12.1 Hz, J2 = J3 = 4.4 Hz, 2H, H-
3'eq(i), H-3'eq(ii)), 1.92-1.74 (m, 4H, H-2ax(i), H-2ax(ii), H-3'ax(i), H-3'ax(ii)), 1.57 (m, 4H, 
SCH2(CH2)10CH3(i), SCH2(CH2)10CH3 (ii)), 1.30 (m, 4H, SCH2(CH2)10CH3(i), SCH2(CH2)10CH3(ii)), 
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1.22-1.10 (m, 32H, SCH2(CH2)10CH3(i), SCH2(CH2)10CH3(ii)), 0.71 (t, 6H, J = 6.9 Hz, 
SCH2(CH2)10CH3(i), SCH2(CH2)10CH3(ii)); 13C NMR (100 MHz, D2O) (Fig. S38) δ 162.9 (q, J = 
35 Hz, CF3CO2H), 116.3 (q, J = 290 Hz, CF3CO2H), 101.2 (anomeric C(ii)), 100.7 (anomeric 
C(i)), 94.4 (anomeric C(ii)), 93.9 (anomeric C(i)), 84.8(ii), 84.4(i), 77.2(ii), 76.5(i), 74.4(i), 74.2(ii), 
70.1(i), 69.0(i), 68.4(ii), 68.3(i), 68.1(ii), 67.9(i), 66.8(ii), 64.5(i), 54.7(i), 54.6(ii), 51.8, 51.1(ii), 51.0(ii), 
49.7(ii), 49.5(i), 49.4(i), 48.3(i), 48.2(ii), 47.9(ii), 47.8(i), 39.9(i), 31.2(i), 29.6, 29.3, 28.7, 28.6, 28.5, 
28.4, 28.2, 28.1, 27.7, 27.6, 22.0(i), 21.7(ii), 13.4; HRESI-MS m/z calc’d for C30H62N5O9S 
668.4268, found 668.4271 [M+H]+. 
 
6"-sulfoxide TOB derivative 5e. Compound 3e (130 mg, 0.11 
mmol) dissolved in CHCl3 (3.5 mL) was treated with m-
chloroperbenzoic acid (70-75%) (26 mg, ~0.15 mmol). The 
reaction mixture was stirred at rt and progress of the reaction was monitored by ESI-MS by 
following the disappearance of the starting material ([M+H]+, m/z 1181.22) and the formation of 
the corresponding sulfoxide ([M+H]+, m/z 1197.22). (Note: small quantities of the corresponding 
sulfone ([M+H]+, m/z 1213.21) and of the starting material ([M+H]+, m/z 1181.22) were in the 
mixture that was further processed). Upon near completion, the reaction mixture was diluted 
with CHCl3 (15 mL), washed with 1 M KOH (2 mL), and concentrated under reduced pressure. 
Further purification by flash column chromatography (SiO2, MeOH:CH2Cl2) gave the Boc-
protected diastereomeric mixture of the sulfoxide (50 mg, 38%) that was then treated with 95% 
TFA (0.4 mL) for 3 min. The TFA was removed under reduced pressure, the residue was 
dissolved in a minimal volume of H2O and freeze-dried to afford 5e (46 mg, 87%) as a white 
foam. (Note: A mixture of 2 diastereomers (~4:1 ratio) was obtained. The major and minor 
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diastereomers are designated as (i) and (ii), respectively): 1H NMR (400 MHz, D2O) (Fig. S39) δ 
5.69 (d, J = 3.5 Hz, 1H, H-1'(i)), 5.63 (d, J = 3.4 Hz, 1H, H-1'(ii)), 4.95-4.92 (m, 2H, H-1"(i), H-
1"(ii)), 4.26 (br app. td, J1 = J2 = 9.2 Hz, J3 = 1.7 Hz, 1H, H-5"(i)), 4.07 (m, 1H, H-5"(ii)), 3.88-
3.69 (m, 8H, H-4(i), H-4(ii), H-5(i), H-5(ii), H-5'(i), H-5'(ii), H-2"(i), H-2"(ii)), 3.65-3.35 (m, 14H, H-
1(i), H-1(ii), H-3(i), H-3(ii), H-6(i), H-6(ii), H-2'(i), H-2'(ii), H-4'(i), H-4'(ii), H-3"(i), H-3"(ii), H-4"(i), 
H-4"(ii)), 3.31-3.18 (m, 4H, H-6'(i), H-6'(ii), H-6"(i), H-6"(ii)), 3.10 (m, 2H, H-6'(i), H-6'(ii)), 2.96-
2.74 (m, 6H, H-6"(i), H-6"(ii), SCH2(CH2)12CH3(i), SCH2(CH2)12CH3(ii)), 2.41 (app. dt, J1 = 12.0 Hz, 
J2 = J3 = 4.2 Hz, 2H, H-2eq(i), H-2eq(ii)), 2.15 (app. dt, J1 = 12.1 Hz, J2 = J3 = 4.3 Hz, 2H, H-
3'eq(i), H-3'eq(ii)), 1.93-1.74 (m, 4H, H-2ax(i), H-2ax(ii), H-3'ax(i), H-3'ax(ii)), 1.55 (m, 4H, 
SCH2(CH2)12CH3(i), SCH2(CH2)12CH3 (ii)), 1.29 (m, 4H, SCH2(CH2)12CH3(i), SCH2(CH2)12CH3(ii)), 
1.20-1.10 (m, 40H, SCH2(CH2)12CH3(i), SCH2(CH2)12CH3(ii)), 0.71 (t, 6H, J = 7.0 Hz, 
SCH2(CH2)12CH3(i), SCH2(CH2)10CH3(ii)); 13C NMR (100 MHz, D2O) (Fig. S40) δ 163.6 (q, J = 
35 Hz, CF3CO2H), 117.0 (q, J = 290 Hz, CF3CO2H), 101.9 (anomeric C(ii)), 101.4 (anomeric 
C(i)), 95.0 (anomeric C(ii)), 94.5 (anomeric C(i)), 85.5(ii), 85.2(i), 77.8(ii), 77.1(i), 75.1(i), 74.9(ii), 
70.8(i), 69.6(i), 69.2(ii), 69.0(i), 68.8(ii), 68.6(i), 67.4(ii), 65.2(i), 55.4(i), 55.3(ii), 52.5(i), 51.9(ii), 
50.3(ii), 50.1(i), 49.0(i), 48.9, 48.6, 48.5(i), 40.6(i), 32.0(ii), 30.0, 29.6, 29.3, 29.0, 28.4, 22.8(i), 
22.5(ii), 14.2; HRESI-MS m/z calc’d for C32H66N5O9S 696.4581, found 696.4584 [M+H]+. 
 
2.4. Oxidation of 6"-thioether TOB derivatives 3d-e into 6"-sulfone TOB derivatives 6d-e. 
6"-sulfone TOB derivative 6d. Compound 6d was prepared as 
5d using compound 3d (37 mg, 0.03 mmol), CHCl3 (1 mL), m-
chloroperbenzoic acid (70-75%) (20 mg, ~0.11 mmol) at rt. ESI-
MS indicated the disappearance of the starting material ([M+H]+, 
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m/z 1153.20) and the formation of the corresponding sulfone ([M+H]+, m/z 1185.02). 
Deprotection using 95% TFA (0.4 mL) for 3 min gave 6d (32 mg, 85%) as a white foam: 1H 
NMR (400 MHz, D2O) (Fig. S41) δ 5.54 (d, J = 3.6 Hz, 1H, H-1'), 5.00 (d, J = 3.7 Hz, 1H, H-
1"), 4.29 (app. td, J1 = J2 = 9.7 Hz, J3 = 1.2 Hz, 1H, H-5"), 3.89-3.77 (m, 4H, H-4, H-5, H-5', H-
2"), 3.66 (dd, J1 = 10.2 Hz, J2 = 8.6 Hz, 1H, H-6), 3.60-3.36 (m, 8H, H-1, H-3, H-2', H-4', H-3", 
H-4", H-6"(2H)), 3.28 (dd, J1 =13.6 Hz, J2 = 3.5 Hz, 1H, H-6'), 3.18 (m, 2H, SCH2(CH2)10CH3), 
3.10 (dd, J1 = 13.6 Hz, J2 = 6.9 Hz, 1H, H-6'), 2.43 (app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz, 1H, 
H-2eq), 2.16 (app. dt, J1 = 11.9 Hz, J2 = J3 = 4.4 Hz, 1H, H-3'eq), 1.86 (app. q, J1 = J2 = J3 = 11.3 
Hz, 1H, H-3'ax), 1.80 (app. q, J1 = J2 = J3 = 12.6 Hz, 1H, H-2ax), 1.65 (m, 2H, 
SCH2(CH2)10CH3), 1.30 (m, 2H, SCH2(CH2)10CH3),1.20-1.10 (m, 16H, SCH2(CH2)10CH3), 0.71 (t, 
3H, J = 7.0 Hz, SCH2(CH2)10CH3); 13C NMR (100 MHz, D2O) (Fig. S42) δ 162.9 (q, J = 35 Hz, 
CF3CO2H), 116.3 (q, J = 290 Hz, CF3CO2H), 100.5 (anomeric C), 95.0 (anomeric C), 84.3, 77.7, 
74.6, 69.9, 67.7, 67.65, 67.5, 64.5, 54.5, 54.1, 52.3, 49.2, 48.1, 48.0, 39.9, 31.2, 29.6, 29.4, 28.7, 
28.6, 28.5, 28.4, 28.0, 27.7, 27.4, 22.0, 21.1, 13.4; HRESI-MS m/z calc’d for C30H62N5O10S 
684.4217, found 684.4216 [M+H]+. 
 
6"-sulfone TOB derivative 6e. Compound 6e was prepared as 5e 
using compound 3e (63 mg, 0.05 mmol), CHCl3 (1.5 mL), m-
chloroperbenzoic acid (70-75%) (35 mg, ~0.20 mmol) at rt. ESI-
MS indicated the disappearance of the starting material ([M+H]+, m/z 1181.22) and the formation 
of the corresponding sulfone ([M+H]+, m/z 1213.21). Deprotection using 95% TFA (0.4 mL) for 
3 min gave 6e (44 mg, 70%) as a white foam: 1H NMR (400 MHz, D2O) (Fig. S43) δ 5.54 (d, J = 
3.6 Hz, 1H, H-1'), 5.00 (d, J = 3.7 Hz, 1H, H-1"), 4.29 (app. td, J1 = J2 = 9.6 Hz, J3 = 1.2 Hz, 1H, 
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H-5"), 3.89-3.77 (m, 4H, H-4, H-5, H-5', H-2"), 3.66 (dd, J1 = 10.3 Hz, J2 = 8.4 Hz, 1H, H-6), 
3.60-3.35 (m, 8H, H-1, H-3, H-2', H-4', H-3", H-4"H-6"(2H)), 3.28 (dd, J1 =13.6 Hz, J2 = 3.6 Hz, 
1H, H-6'), 3.18 (m, 2H, SCH2(CH2)12CH3), 3.10 (dd, J1 = 13.6 Hz, J2 = 6.9 Hz, 1H, H-6'), 2.42 
(app. dt, J1 = 12.6 Hz, J2 = J3 = 4.2 Hz, 1H, H-2eq), 2.16 (app. dt, J1 = 11.9 Hz, J2 = J3 = 4.2 Hz, 
1H, H-3'eq), 1.85 (app. q, J1 = J2 = J3 = 11.0 Hz, 1H, H-3'ax), 1.79 (app. q, J1 = J2 = J3 = 12.5 Hz, 
1H, H-2ax), 1.65 (m, 2H, SCH2(CH2)12CH3), 1.30 (m, 2H, SCH2(CH2)12CH3),1.20-1.10 (m, 20H, 
SCH2(CH2)12CH3), 0.71 (t, 3H, J = 7.0 Hz, SCH2(CH2)12CH3); 13C NMR (100 MHz, D2O) (Fig. 
S44) δ 163.7 (q, J = 35 Hz, CF3CO2H), 117.1 (q, J = 290 Hz, CF3CO2H), 101.2 (anomeric C), 
95.8 (anomeric C), 85.0, 78.5, 75.3, 70.7, 68.5, 68.3, 68.2, 65.3, 55.2, 54.8, 53.1, 49.9, 48.8, 
48.7, 40.7, 31.9, 30.3, 30.1, 29.5, 29.4, 29.3, 29.2, 29.1, 28.8, 28.5, 28.1, 22.8, 21.8, 14.1; 
HRESI-MS m/z calc’d for C32H65N5O10SNa 734.4350, found 734.4348 [M+H]+. 
 
3. Biochemical methods 
3.1. Determination of MIC values of 6"-thioether TOB derivatives 4a-r. 
MIC values were determined against a variety of Gram-positive bacterial strains: S. epidermidis 
ATCC12228 (A), S. aureus NorA (B), MRSA (C), S. pyogenes serotype M12 (strain 
MGAS9429) (D), S. mutans UA159 (E), B. subtilis 168 (F), B. subtilis 168 with 
AAC(6')/APH(2")-pRB374 (G), B. cereus ATCC11778 (H), B. anthracis 34F2 Sterne strain (I), 
VRE (J), E. faecalis ATCC29212 (K), and L. monocytogenes ATCC19115 (L). MIC values 
were also determined against a variety of Gram-negative bacterial strains: E. coli BL21 (DE3) 
(M), E. coli BL21 (DE3) with pET22b (N), E. coli BL21 (DE3) with AAC(6')/APH(2")-pET22b 
(O), E. coli BL21 (DE3) with AAC(3)-IV-Int-pET19b-pps (P), E. coli BL21 (DE3) with Eis (Q), 
E. coli TolC (R), E. coli MC1061 (S), Shigella clinical isolate 6831 (T), and S. enterica 
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ATCC14028 (U). Strains were tested using a double-dilution of 6"-thioether TOB derivatives 4a-
r starting at 150 µg/mL (Fig. S45A). All experiments were performed in two separate sets of 
duplicate or triplicate experiments. MIC values were confirmed by the addition of MTT (50 µL 
of a 1 mg/mL solution in H2O). 
 
3.2. Prokaryotic protein translation inhibition test (luciferase assay system).  
The prokaryotic in vitro translation inhibition by TOB (1) and the 6"-thioether TOB derivative 
4e was quantified in coupled transcription/translation assays7 by using E. coli S30 extract for 
circular DNA with the pBESTluc plasmid (Promega), according to the manufacturer′s protocol. 
Translation reactions (10 µL) containing various concentrations of the tested compounds (0.1, 
0.5, 1, 5, 10, 25, 50, and 100 ng/mL) were incubated at 37 °C for 90 min, cooled on ice for 
5 min, and diluted with a dilution reagent (tris-phosphate buffer (25 mM, pH 7.8 adjusted at rt), 
DTT (2 mM), 1,2-diaminocyclohexanetetraacetate (2 mM), glycerol (10%), Triton X-100 (1%), 
and BSA (1 mg/mL)) into 96-well plates. The luminescence was measured immediately after the 
addition of the luciferase assay reagent (50 µL, Promega), and the light emission was recorded 
with a FLx800 Fluorescence Microplate Reader (Biotek). The half-maximal inhibition 
concentration (IC50) values were obtained from fitting concentration-response curves to the data 
of at least two independent experiments by using Grafit 5 software. 
 
3.3. Time-kill kinetic study of TOB (1) and 4e against S. mutans UA159 and S. pyogenes 
serotype M12 (strain MGAS9429). 
To determine the time-kill kinetic against S. mutans UA159 and S. pyogenes serotype M12 
(strain MGAS9429), the bacteria were grown aerobically (37 °C, 5% CO2, overnight) from a 
	   37 
frozen glycerol stock kept at -80 °C in Brain Heart Infustion (BHI) broth (BBL Microbiology 
Systems, Cockeysville, MD, USA) (25 mL) until they reached stationary phase. The overnight 
culture was then diluted into BHI broth (1 mL of overnight culture into 250 mL of fresh broth). 
The diluted S. mutans UA159 and S. pyogenes cultures were then aliquoted (1 mL/well) into 12-
well plates (Nunc, Rochester, NY, USA) and incubated in the presence of TOB (1) (75 µg/mL 
for S. mutans and 18.8 µg/mL for S. pyogenes = 1× MIC) or of the 6"-thioether TOB derivative 
4e (2.3 µg/mL = 1× MIC) and grown aerobically (37 °C, 5% CO2) for a total of 5 h. A positive 
control consisted of aliquots (1 mL) of S. mutans UA159 or S. pyogenes cultures incubated in the 
absence of antibiotic. Immediately (time 0), and after 10 min, 1, 2, 3, 4, and 5 h, an aliquot (5 
µL) was diluted (10-, 103-, and 106-fold) into BHI broth and 10 µL of each dilution (50 µL total) 
were plated in duplicate on BHI agar (BBL Microbiology Systems) plates. After exactly 24 h 
(starting from each tested time point) of incubation, the number of colonies on each plate was 
counted using a colony counter. Time-kill assays were analyzed by determining the reductions in 
viable count (CFU/mL) at the above time points by TOB (1) and compound 4e as compared with 
the positive control (Fig. S45B). All duplicate experiments were performed 3 times. 
 
3.4. Epi-fluorescence microscopy using the 6"-thioether TOB derivative 4e. 
To verify if compound 4e targets the bacterial membrane, B. subtilis PY79 cells carrying YFP 
under an inducible IPTG promoter8 were used. This bacterial strain was constructed by cloning 
of the constitutive trpE promoter into the B. subtilis PY79 integration plasmid AEC127 designed 
to integrate into the sacA position and carrying a yfp gene. Cloning was done using standard 
techniques in E. coli DH5α. B. subtilis PY79 cells carrying YFP under an inducible IPTG 
promoter from a freshly streaked plate were grown (37 °C, ∼14 h) in Luria-Bertani (LB) broth (3 
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mL) supplemented with tetracycline (10 µg/mL) and IPTG (1 mM). The overnight culture (0.1 
mL) was diluted into fresh LB broth (10 mL) containing IPTG (1 mM) and grown to an OD600 of 
0.5. The cells were then treated with either TOB (1) (2.3 µg/mL (2× MIC) and 9.4 µg/mL (8× 
MIC)) or with the 6"-thioether TOB derivative 4e (4.7 µg/mL (2× MIC) and 18.8 µg/mL (8× 
MIC)) and continued to grow at 37 °C. After 1 h in the presence of 1 or 4e, aliquots (1 µL) were 
put on agar slabs made of PBS. Snapshots fluorescence images were taken with a 100× lens of an 
inverted epi-fluorescence microscope (Nikon TiE, Nikon, Japan). 
 
3.5. Determination of AME activity on the 6"-thioether TOB derivatives 4a-r. 
To determine the activity of the modified TOB AGs (4a-r, 5d-e, and 6d-e) with various AMEs, 
several previously developed assays were utilized to monitor the transformation of the AGs 
(Figs. 3 (in the main text) and S46). 
 
Acetylation: 
The acetylation activity of several AACs (AAC(6')/APH(2"),1; 2 AAC(6')-Ib',3 AAC(6')-IId, 
AAC(3)-IV,1; 2 AAC(2')-Ic,4 and Eis4) was monitored using the Ellman’s method where the 
reaction of the CoASH released during acetylation is reacted with DTNB and monitored at 412 
nm. Briefly, reactions (200 µL) containing AG (100 µM) and AcCoA (500 µM for Eis or 150 
µM for the remaining AACs) were incubated with AAC enzyme (0.125 µM AAC(2')-Ic and 
AAC(3)-IV or 0.5 µM for all remaining AACs) in the presence of DTNB (2 mM) and the 
appropriate buffer (50 mM MES pH 6.6 for AAC(6')/APH(2") and AAC(3)-IV, 50 mM Tris pH 
7.5 for AAC(6')-Ib' and AAC(6')-IId, 50 mM Tris pH 8.0 for Eis, and 100 mM sodium phosphate 
pH 7.4 for AAC(2')-Ic). The reactions were monitored at 37 °C (AAC(6')/APH(2")) or 25 °C 
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(AAC(6')-Ib', AAC(6')-IId, AAC(3)-IV, AAC(2')-Ic, and Eis) on a SpectraMax M5 microplate 
reader, taking measurements every 30 s for 1 h. The initial rates of the reactions were calculated 
using the first 2 min of the reaction (AAC(3)-IV) or the first 10 min (all remaining AACs) and 
normalized to TOB (1). All experiments were performed in triplicate. 
 
Nucleotidylation: 
The nucleotidyltransferase activity of the ANT(4') was monitored at 600 nm through the 
complex formation of molybdate in malachite green and the Pi generated by inorganic 
pyrophosphatase cleavage of the released PPi during the ANT catalyzed reaction.5; 9 To analyze 
the activity of ANT(4') on the 6"-thioether TOB derivatives (4a-r) as well as the sulfoxide and 
sulfone derivatives 5d-e and 6d-e, reactions (160 µL) containing Tris-HCl (50 mM, pH 7.5), 
MgCl2 (10 mM), KCl (50 mM), inorganic pyrophosphatase (0.2 U/mL), AG (100 µM), and ATP 
(0.5 mM) were performed at 25 °C. The reactions were initiated by addition of ANT(4') (1 µM), 
incubated for 15, 30, 45, 60, and 75 s, and quenched with the molybdate/malachite green reagent 
(40 µL) to terminate the reaction. After 15 min of color development, the liberated Pi 
concentration was measured by absorbance at 600 nm. The initial rates were determined using 
the first 60 sec of reaction time. All experiments were performed in triplicate. 
 
3.6. Red blood cells (RBC) lysis assay. 
Rat or human RBC solution (2% w/w) was incubated with 6"-thioether TOB analogues 4b-h 
(18.8 µg/mL as well as 75 µg/mL, 1 h, 37 °C). Negative controls were PBS and Dextran (MW 
~70,000 Da) while positive controls were 1% w/v solution of Triton X100 (100% lysis). 
Following centrifugation (2,000 rpm, 10 min, rt), the supernatant was drawn off and its 
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absorbance measured at 550 nm using a microplate reader (Genios, TECAN). The results were 
expressed as percentage of hemoglobin released relative to the positive control (Triton X100). 
 
4. Abbreviations. 
AAC, aminoglycoside acetyltransferase; AG, aminoglycoside; AME, aminoglycoside-modifying 
enzyme; ANT, aminoglycoside nucelotidyltransferase; APH, aminoglycoside 
phosphotransferase; BHI, brain heart infusion; BOC, di-tert-butyl dicarbonate; BSA, bovine 
serum albumin; DMF, dimethylformamide; DTT, dithiothreitol; EtOAc, ethyl acetate; IPTG, 
Isopropyl β-D-1-thiogalactopyranoside; MIC, minimum inhibitory concentration; MTT, thiazolyl 
blue tetrazolium bromide; PBS, phosphate buffered saline; Pi, inorganic phosphate; PPi, 
inorganic pyrophosphate; RBC, red blood cells; rt, room temperature; TFA, trifluoroacetic acid; 
TLC, thin layer chromatography; TOB, tobramycin; XDR, extensively-drug resistant; YFP, 
yellow fluorescent protein. 
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6. Supporting information Figs. S1-S45. 
 
 
Fig. S1. 1H NMR for 6"-thioether TOB derivative 4a. 
 
Fig. S2. 13C NMR for 6"-thioether TOB derivative 4a. 
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Fig. S3. 1H NMR for 6"-thioether TOB derivative 4b. 
 
Fig. S4. 13C NMR for 6"-thioether TOB derivative 4b. 
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Fig. S5. 1H NMR for 6"-thioether TOB derivative 4c. 
 
Fig. S6. 13C NMR for 6"-thioether TOB derivative 4c. 
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Fig. S7. 1H NMR for 6"-thioether TOB derivative 4d. 
 
Fig. S8. 13C NMR for 6"-thioether TOB derivative 4d. 
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Fig. S9. 1H NMR for 6"-thioether TOB derivative 4e. 
 
Fig. S10. 13C NMR for 6"-thioether TOB derivative 4e. 
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Fig. S11. 1H NMR for 6"-thioether TOB derivative 4f. 
 
Fig. S12. 13C NMR for 6"-thioether TOB derivative 4f. 
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Fig. S13. 1H NMR for 6"-thioether TOB derivative 4g. 
 
Fig. S14. 13C NMR for 6"-thioether TOB derivative 4g. 
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Fig. S15. 1H NMR for 6"-thioether TOB derivative 4h. 
 
Fig. S16. 13C NMR for 6"-thioether TOB derivative 4h. 
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Fig. S17. 1H NMR for 6"-thioether TOB derivative 4i. 
 
Fig. S18. 13C NMR for 6"-thioether TOB derivative 4i. 
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Fig. S19. 1H NMR for 6"-thioether TOB derivative 4j. 
 
Fig. S20. 13C NMR for 6"-thioether TOB derivative 4j. 
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Fig. S21. 1H NMR for 6"-thioether TOB derivative 4k. 
 
Fig. S22. 13C NMR for 6"-thioether TOB derivative 4k. 
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Fig. S23. 1H NMR for 6"-thioether TOB derivative 4l. 
 
Fig. S24. 13C NMR for 6"-thioether TOB derivative 4l. 
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Fig. S25. 1H NMR for 6"-thioether TOB derivative 4m. 
 
Fig. S26. 13C NMR for 6"-thioether TOB derivative 4m. 
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Fig. S27. 1H NMR for 6"-thioether TOB derivative 4n. 
 
Fig. S28. 13C NMR for 6"-thioether TOB derivative 4n. 
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Fig. S29. 1H NMR for 6"-thioether TOB derivative 4o. 
 
Fig. S30. 13C NMR for 6"-thioether TOB derivative 4o. 
!
"#$
#!
#$" !
"#$
"#$
!
#!
!
!#
#$"
#!
%
!" # $ % & ' ( ) * ! ++,
!
"#$
#!
#$" !
"#$
"#$
!
#!
!
!#
#$"
#!
%
!"" #$" #%" #&" #'" #(" #)" #*" #!" ##" #"" $" %" &" '" (" )" *" !" #" ++,
	   57 
 
Fig. S31. 1H NMR for 6"-thioether TOB derivative 4p. 
 
Fig. S32. 13C NMR for 6"-thioether TOB derivative 4p. 
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Fig. S33. 1H NMR for 6"-thioether TOB derivative 4q. 
 
Fig. S34. 13C NMR for 6"-thioether TOB derivative 4q. 
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Fig. S35. 1H NMR for 6"-thioether TOB derivative 4r. 
 
Fig. S36. 13C NMR for 6"-thioether TOB derivative 4r. 
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Fig. S37. 1H NMR for 6"-sulfoxide TOB derivative 5d. 
 
Fig. S38. 13C NMR for 6"-sulfoxide TOB derivative 5d. 
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Fig. S39. 1H NMR for 6"-sulfoxide TOB derivative 5e. 
 
Fig. S40. 13C NMR for 6"-sulfoxide TOB derivative 5e. 
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Fig. S41. 1H NMR for 6"-sulfone TOB derivative 6d. 
 
Fig. S42. 13C NMR for 6"-sulfone TOB derivative 6d. 
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Fig. S43. 1H NMR for 6"-sulfone TOB derivative 6e. 
 
Fig. S44. 13C NMR for 6"-sulfone TOB derivative 6e. 
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Fig. S45. A. The effect of aliphatic tail length on MIC values of Gram-positive and Gram-negative bacterial strains. 
B. Time-kill kinetics towards S. mutans UA159 (circle) and S. pyogenes serotype M12 (strain MGAS9429) 
(triangle) with TOB (1) or compound 4e at 1× MIC (75 µg/mL of 1 (S. mutans) or 18.8 µg/mL of 1 (S. pyogenes)) 
and 2.3 µg/mL of 4e). After 0, 10 min, 1, 2, 3, 4, and 5 h, an aliquot (5 µL) was diluted (10-, 103-, and 106-fold) into 
BHI broth and 10 µL of each dilution (50 µL total) were plated in duplicate on BHI agar plates. After exactly 24 h 
(starting from each tested time point) of incubation, the number of colonies on each plate was counted using a 
colony counter. Time-kill assays were analyzed by determining the reductions in viable count (CFU/mL). Triplicate 
experiments were repeated twice. 
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Fig. S46. Bar graph showing the relative initial rates of AME reactions with TOB and the 6"-thioether analogues 4d-
e and their corresponding sulfoxides (5d-e) and sulfones (6d-e). Rates are normalized to TOB and experiments were 
performed in triplicate. AMEs tested include AAC(6')-IId (blue), AAC(6')-Ib (cyan), AAC(6')/APH(2") (dark 
green), Eis (light green), AAC(3)-IV (yellow), AAC(2')-Ic (orange), and ANT(4') (red). 
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